EA031003B1 - Способы и фармацевтические композиции для лечения вызванных вирусом гепатита в инфекций - Google Patents

Info

Publication number

EA031003B1

EA031003B1 EA201690556A EA201690556A EA031003B1 EA 031003 B1 EA031003 B1 EA 031003B1 EA 201690556 A EA201690556 A EA 201690556A EA 201690556 A EA201690556 A EA 201690556A EA 031003 B1 EA031003 B1 EA 031003B1

Authority

EA

Eurasian Patent Office

Prior art keywords

benzimidazol

phenyl

acetamide

chloro

benzofuran

Prior art date

2013-09-11

Links

• Espacenet
• Global Dossier
• Discuss

• 238000011282 treatment Methods 0.000 title claims abstract description 58
• 238000000034 method Methods 0.000 title claims abstract description 31
• 208000002672 hepatitis B Diseases 0.000 title abstract description 9
• 239000008194 pharmaceutical composition Substances 0.000 title abstract description 7
• 229940121360 farnesoid X receptor (fxr) agonists Drugs 0.000 claims abstract description 84
• 102100038495 Bile acid receptor Human genes 0.000 claims description 64
• 101000603876 Homo sapiens Bile acid receptor Proteins 0.000 claims description 62
• 208000015181 infectious disease Diseases 0.000 claims description 48
• 230000014509 gene expression Effects 0.000 claims description 37
• 150000001875 compounds Chemical class 0.000 claims description 25
• ZXERDUOLZKYMJM-ZWECCWDJSA-N obeticholic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)CCC(O)=O)CC[C@H]21 ZXERDUOLZKYMJM-ZWECCWDJSA-N 0.000 claims description 19
• 229960001601 obeticholic acid Drugs 0.000 claims description 19
• BYTNEISLBIENSA-MDZDMXLPSA-N GW 4064 Chemical compound CC(C)C=1ON=C(C=2C(=CC=CC=2Cl)Cl)C=1COC(C=C1Cl)=CC=C1\C=C\C1=CC=CC(C(O)=O)=C1 BYTNEISLBIENSA-MDZDMXLPSA-N 0.000 claims description 17
• 241000700721 Hepatitis B virus Species 0.000 claims description 15
• 239000003443 antiviral agent Substances 0.000 claims description 11
• WOZSCQDILHKSGG-UHFFFAOYSA-N adefovir depivoxil Chemical compound N1=CN=C2N(CCOCP(=O)(OCOC(=O)C(C)(C)C)OCOC(=O)C(C)(C)C)C=NC2=C1N WOZSCQDILHKSGG-UHFFFAOYSA-N 0.000 claims description 9
• QDGZDCVAUDNJFG-FXQIFTODSA-N entecavir (anhydrous) Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@H]1C[C@H](O)[C@@H](CO)C1=C QDGZDCVAUDNJFG-FXQIFTODSA-N 0.000 claims description 8
• JTEGQNOMFQHVDC-NKWVEPMBSA-N lamivudine Chemical compound O=C1N=C(N)C=CN1[C@H]1O[C@@H](CO)SC1 JTEGQNOMFQHVDC-NKWVEPMBSA-N 0.000 claims description 8
• IQFYYKKMVGJFEH-CSMHCCOUSA-N telbivudine Chemical compound O=C1NC(=O)C(C)=CN1[C@H]1O[C@@H](CO)[C@H](O)C1 IQFYYKKMVGJFEH-CSMHCCOUSA-N 0.000 claims description 7
• XLGQSYUNOIJBNR-UHFFFAOYSA-N vonafexor Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Cl)C=1N(CC1)CCN1S(=O)(=O)C1=C(Cl)C=CC=C1Cl XLGQSYUNOIJBNR-UHFFFAOYSA-N 0.000 claims description 6
• 229960001997 adefovir Drugs 0.000 claims description 5
• 102100040018 Interferon alpha-2 Human genes 0.000 claims description 4
• 108010079944 Interferon-alpha2b Proteins 0.000 claims description 4
• 229940002637 baraclude Drugs 0.000 claims description 4
• 230000001684 chronic effect Effects 0.000 claims description 4
• 229960000980 entecavir Drugs 0.000 claims description 4
• 229940097709 hepsera Drugs 0.000 claims description 4
• 210000000987 immune system Anatomy 0.000 claims description 4
• 229940002988 pegasys Drugs 0.000 claims description 4
• 108010092853 peginterferon alfa-2a Proteins 0.000 claims description 4
• 108010092851 peginterferon alfa-2b Proteins 0.000 claims description 4
• SGOIRFVFHAKUTI-ZCFIWIBFSA-N tenofovir (anhydrous) Chemical compound N1=CN=C2N(C[C@@H](C)OCP(O)(O)=O)C=NC2=C1N SGOIRFVFHAKUTI-ZCFIWIBFSA-N 0.000 claims description 4
• 229940063032 tyzeka Drugs 0.000 claims description 4
• IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 claims description 3
• 229960005311 telbivudine Drugs 0.000 claims description 3
• 108010047761 Interferon-alpha Proteins 0.000 claims 4
• 102000006992 Interferon-alpha Human genes 0.000 claims 4
• 239000003795 chemical substances by application Substances 0.000 claims 1
• -1 nucleoside phosphonates Chemical class 0.000 description 165
• 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 46
• 210000004027 cell Anatomy 0.000 description 44
• 230000000694 effects Effects 0.000 description 34
• 230000028327 secretion Effects 0.000 description 33
• DLFVBJFMPXGRIB-UHFFFAOYSA-N thioacetamide Natural products CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 33
• 108090000623 proteins and genes Proteins 0.000 description 21
• 241000700605 Viruses Species 0.000 description 20
• 108020004999 messenger RNA Proteins 0.000 description 20
• 239000003613 bile acid Substances 0.000 description 18
• 108020004414 DNA Proteins 0.000 description 16
• 239000000556 agonist Substances 0.000 description 16
• 239000000203 mixture Substances 0.000 description 15
• 230000010076 replication Effects 0.000 description 15
• RUDATBOHQWOJDD-UHFFFAOYSA-N (3beta,5beta,7alpha)-3,7-Dihydroxycholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)CC2 RUDATBOHQWOJDD-UHFFFAOYSA-N 0.000 description 13
• 108010067390 Viral Proteins Proteins 0.000 description 12
• 201000010099 disease Diseases 0.000 description 12
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 12
• RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 12
• 239000006228 supernatant Substances 0.000 description 12
• 239000005557 antagonist Substances 0.000 description 11
• 231100000673 dose–response relationship Toxicity 0.000 description 11
• 229940079593 drug Drugs 0.000 description 11
• 239000003814 drug Substances 0.000 description 11
• VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 10
• 210000002966 serum Anatomy 0.000 description 10
• 239000000243 solution Substances 0.000 description 10
• PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 9
• 108010036949 Cyclosporine Proteins 0.000 description 9
• 108010050904 Interferons Proteins 0.000 description 9
• 102000014150 Interferons Human genes 0.000 description 9
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 9
• 239000002253 acid Substances 0.000 description 9
• 229960001265 ciclosporin Drugs 0.000 description 9
• 230000007423 decrease Effects 0.000 description 9
• 102000004169 proteins and genes Human genes 0.000 description 9
• 150000003839 salts Chemical group 0.000 description 9
• HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 8
• 229930105110 Cyclosporin A Natural products 0.000 description 8
• 101000978937 Homo sapiens Nuclear receptor subfamily 0 group B member 2 Proteins 0.000 description 8
• 102100023172 Nuclear receptor subfamily 0 group B member 2 Human genes 0.000 description 8
• 101001082043 Sulfolobus acidocaldarius (strain ATCC 33909 / DSM 639 / JCM 8929 / NBRC 15157 / NCIMB 11770) Translation initiation factor 5A Proteins 0.000 description 8
• 230000015572 biosynthetic process Effects 0.000 description 8
• 230000002829 reductive effect Effects 0.000 description 8
• 238000002560 therapeutic procedure Methods 0.000 description 8
• RUDATBOHQWOJDD-UZVSRGJWSA-N ursodeoxycholic acid Chemical compound C([C@H]1C[C@@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 RUDATBOHQWOJDD-UZVSRGJWSA-N 0.000 description 8
• 108091006611 SLC10A1 Proteins 0.000 description 7
• 102100021988 Sodium/bile acid cotransporter Human genes 0.000 description 7
• 210000003494 hepatocyte Anatomy 0.000 description 7
• 238000002347 injection Methods 0.000 description 7
• 239000007924 injection Substances 0.000 description 7
• 229940079322 interferon Drugs 0.000 description 7
• 230000035515 penetration Effects 0.000 description 7
• 238000003786 synthesis reaction Methods 0.000 description 7
• 210000002845 virion Anatomy 0.000 description 7
• 125000001617 2,3-dimethoxy phenyl group Chemical group [H]C1=C([H])C(*)=C(OC([H])([H])[H])C(OC([H])([H])[H])=C1[H] 0.000 description 6
• 102100033715 Apolipoprotein A-I Human genes 0.000 description 6
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 6
• 101000733802 Homo sapiens Apolipoprotein A-I Proteins 0.000 description 6
• DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
• 108020005202 Viral DNA Proteins 0.000 description 6
• 108091007433 antigens Proteins 0.000 description 6
• 102000036639 antigens Human genes 0.000 description 6
• 230000001413 cellular effect Effects 0.000 description 6
• RUDATBOHQWOJDD-BSWAIDMHSA-N chenodeoxycholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 RUDATBOHQWOJDD-BSWAIDMHSA-N 0.000 description 6
• 229960001091 chenodeoxycholic acid Drugs 0.000 description 6
• 230000005764 inhibitory process Effects 0.000 description 6
• 230000003993 interaction Effects 0.000 description 6
• 239000007788 liquid Substances 0.000 description 6
• 238000012423 maintenance Methods 0.000 description 6
• 238000002360 preparation method Methods 0.000 description 6
• 239000011780 sodium chloride Substances 0.000 description 6
• XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 6
• 238000011285 therapeutic regimen Methods 0.000 description 6
• 230000003612 virological effect Effects 0.000 description 6
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
• 101710188315 Protein X Proteins 0.000 description 5
• 239000004480 active ingredient Substances 0.000 description 5
• 239000000427 antigen Substances 0.000 description 5
• 239000006185 dispersion Substances 0.000 description 5
• 239000002552 dosage form Substances 0.000 description 5
• 230000002458 infectious effect Effects 0.000 description 5
• 239000003112 inhibitor Substances 0.000 description 5
• 238000004519 manufacturing process Methods 0.000 description 5
• 238000013518 transcription Methods 0.000 description 5
• 230000035897 transcription Effects 0.000 description 5
• HWOXGSYLOCRIMO-UHFFFAOYSA-N 3-[2-[2-chloro-4-[[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]methoxy]phenyl]cyclopropyl]benzoic acid Chemical compound OC(=O)C1=CC=CC(C2C(C2)C=2C(=CC(OCC=3C(=NOC=3C3CC3)C=3C(=CC=CC=3Cl)Cl)=CC=2)Cl)=C1 HWOXGSYLOCRIMO-UHFFFAOYSA-N 0.000 description 4
• 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 description 4
• XVRQMMDRSOAMJJ-UHFFFAOYSA-N 6-[2-[2-chloro-4-[[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]methoxy]phenyl]cyclopropyl]-1-methylindazole-3-carboxylic acid Chemical compound C1=C2N(C)N=C(C(O)=O)C2=CC=C1C1CC1C(C(=C1)Cl)=CC=C1OCC=1C(C=2C(=CC=CC=2Cl)Cl)=NOC=1C1CC1 XVRQMMDRSOAMJJ-UHFFFAOYSA-N 0.000 description 4
• 208000000419 Chronic Hepatitis B Diseases 0.000 description 4
• 238000000636 Northern blotting Methods 0.000 description 4
• 108020000999 Viral RNA Proteins 0.000 description 4
• 238000002866 fluorescence resonance energy transfer Methods 0.000 description 4
• 230000002401 inhibitory effect Effects 0.000 description 4
• 210000004185 liver Anatomy 0.000 description 4
• 102000006255 nuclear receptors Human genes 0.000 description 4
• 108020004017 nuclear receptors Proteins 0.000 description 4
• 239000002245 particle Substances 0.000 description 4
• 239000000843 powder Substances 0.000 description 4
• 108090000765 processed proteins & peptides Proteins 0.000 description 4
• 102000005962 receptors Human genes 0.000 description 4
• 108020003175 receptors Proteins 0.000 description 4
• 230000001105 regulatory effect Effects 0.000 description 4
• 239000003419 rna directed dna polymerase inhibitor Substances 0.000 description 4
• 230000001225 therapeutic effect Effects 0.000 description 4
• 238000011269 treatment regimen Methods 0.000 description 4
• 230000029812 viral genome replication Effects 0.000 description 4
• XBUXXJUEBFDQHD-UHFFFAOYSA-N 4-[2-[2-chloro-4-[[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]methoxy]phenyl]cyclopropyl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C1C(C=2C(=CC(OCC=3C(=NOC=3C3CC3)C=3C(=CC=CC=3Cl)Cl)=CC=2)Cl)C1 XBUXXJUEBFDQHD-UHFFFAOYSA-N 0.000 description 3
• 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 description 3
• QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
• 239000004471 Glycine Substances 0.000 description 3
• 241000282412 Homo Species 0.000 description 3
• 108020005497 Nuclear hormone receptor Proteins 0.000 description 3
• MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
• 238000011529 RT qPCR Methods 0.000 description 3
• 108700008625 Reporter Genes Proteins 0.000 description 3
• 238000004458 analytical method Methods 0.000 description 3
• 230000000840 anti-viral effect Effects 0.000 description 3
• 239000007864 aqueous solution Substances 0.000 description 3
• 230000027455 binding Effects 0.000 description 3
• 230000037396 body weight Effects 0.000 description 3
• 230000003915 cell function Effects 0.000 description 3
• 230000003247 decreasing effect Effects 0.000 description 3
• 231100000844 hepatocellular carcinoma Toxicity 0.000 description 3
• 206010073071 hepatocellular carcinoma Diseases 0.000 description 3
• 239000004615 ingredient Substances 0.000 description 3
• 239000000543 intermediate Substances 0.000 description 3
• 238000007918 intramuscular administration Methods 0.000 description 3
• 238000001990 intravenous administration Methods 0.000 description 3
• 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 3
• 229960001627 lamivudine Drugs 0.000 description 3
• 239000003446 ligand Substances 0.000 description 3
• 208000019423 liver disease Diseases 0.000 description 3
• 244000005700 microbiome Species 0.000 description 3
• 238000010606 normalization Methods 0.000 description 3
• 239000000546 pharmaceutical excipient Substances 0.000 description 3
• 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
• 238000003752 polymerase chain reaction Methods 0.000 description 3
• 229920001184 polypeptide Polymers 0.000 description 3
• 102000004196 processed proteins & peptides Human genes 0.000 description 3
• 238000003753 real-time PCR Methods 0.000 description 3
• 238000010839 reverse transcription Methods 0.000 description 3
• 239000007787 solid Substances 0.000 description 3
• 238000007920 subcutaneous administration Methods 0.000 description 3
• 230000001629 suppression Effects 0.000 description 3
• 229960003080 taurine Drugs 0.000 description 3
• 238000012360 testing method Methods 0.000 description 3
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
• KCIHDFUMQGXFFF-UHFFFAOYSA-N 2-[[4-[2-[2-chloro-4-[[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]methoxy]phenyl]cyclopropyl]benzoyl]amino]ethanesulfonic acid Chemical compound C1=CC(C(=O)NCCS(=O)(=O)O)=CC=C1C1C(C=2C(=CC(OCC3=C(ON=C3C=3C(=CC=CC=3Cl)Cl)C3CC3)=CC=2)Cl)C1 KCIHDFUMQGXFFF-UHFFFAOYSA-N 0.000 description 2
• 125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 description 2
• 125000004189 3,4-dichlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(Cl)C([H])=C1* 0.000 description 2
• FXPNXNFCBSDNBV-UHFFFAOYSA-N 4-bromo-5-[4-(2-chlorophenyl)sulfonyl-1,4-diazepan-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Br)C=1N(CC1)CCCN1S(=O)(=O)C1=CC=CC=C1Cl FXPNXNFCBSDNBV-UHFFFAOYSA-N 0.000 description 2
• LLFIBDVXUIKRGS-UHFFFAOYSA-N 4-bromo-5-[4-[(2,6-dichlorophenyl)sulfonylamino]piperidin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Br)C=1N(CC1)CCC1NS(=O)(=O)C1=C(Cl)C=CC=C1Cl LLFIBDVXUIKRGS-UHFFFAOYSA-N 0.000 description 2
• 125000004801 4-cyanophenyl group Chemical group [H]C1=C([H])C(C#N)=C([H])C([H])=C1* 0.000 description 2
• OVLGBZJMJCQCMG-UHFFFAOYSA-N 5-[2-[2-chloro-4-[[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]methoxy]phenyl]cyclopropyl]-1-propan-2-ylpyrazole-3-carboxylic acid Chemical compound CC(C)N1N=C(C(O)=O)C=C1C1C(C=2C(=CC(OCC=3C(=NOC=3C3CC3)C=3C(=CC=CC=3Cl)Cl)=CC=2)Cl)C1 OVLGBZJMJCQCMG-UHFFFAOYSA-N 0.000 description 2
• XEWOADJHABYTCZ-UHFFFAOYSA-N 5-[4-(2,6-dichlorobenzoyl)piperazin-1-yl]-4-methyl-1-benzofuran-2-carboxylic acid Chemical compound C1=CC=2OC(C(O)=O)=CC=2C(C)=C1N(CC1)CCN1C(=O)C1=C(Cl)C=CC=C1Cl XEWOADJHABYTCZ-UHFFFAOYSA-N 0.000 description 2
• VDOGFUNVPMEXGT-UHFFFAOYSA-N 6-[2-[2-chloro-4-[[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]methoxy]phenyl]cyclopropyl]-1-propan-2-ylindazole-3-carboxylic acid Chemical compound C1=C2N(C(C)C)N=C(C(O)=O)C2=CC=C1C1CC1C(C(=C1)Cl)=CC=C1OCC1=C(C2CC2)ON=C1C1=C(Cl)C=CC=C1Cl VDOGFUNVPMEXGT-UHFFFAOYSA-N 0.000 description 2
• 206010067484 Adverse reaction Diseases 0.000 description 2
• KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 description 2
• 108070000005 Bile acid receptors Proteins 0.000 description 2
• 208000008439 Biliary Liver Cirrhosis Diseases 0.000 description 2
• 208000033222 Biliary cirrhosis primary Diseases 0.000 description 2
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
• 101710132601 Capsid protein Proteins 0.000 description 2
• 230000004543 DNA replication Effects 0.000 description 2
• 108700039691 Genetic Promoter Regions Proteins 0.000 description 2
• 101000804917 Homo sapiens Xenotropic and polytropic retrovirus receptor 1 Proteins 0.000 description 2
• 206010022489 Insulin Resistance Diseases 0.000 description 2
• 102100034343 Integrase Human genes 0.000 description 2
• TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
• OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
• 241000124008 Mammalia Species 0.000 description 2
• 108700026244 Open Reading Frames Proteins 0.000 description 2
• ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
• NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
• 239000002202 Polyethylene glycol Substances 0.000 description 2
• ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
• 208000012654 Primary biliary cholangitis Diseases 0.000 description 2
• 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 2
• 108700005077 Viral Genes Proteins 0.000 description 2
• 102100036974 Xenotropic and polytropic retrovirus receptor 1 Human genes 0.000 description 2
• 238000010521 absorption reaction Methods 0.000 description 2
• AXJDEHNQPMZKOS-UHFFFAOYSA-N acetylazanium;chloride Chemical compound [Cl-].CC([NH3+])=O AXJDEHNQPMZKOS-UHFFFAOYSA-N 0.000 description 2
• 230000009471 action Effects 0.000 description 2
• 230000004913 activation Effects 0.000 description 2
• 230000006838 adverse reaction Effects 0.000 description 2
• 125000004244 benzofuran-2-yl group Chemical group [H]C1=C(*)OC2=C([H])C([H])=C([H])C([H])=C12 0.000 description 2
• WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
• 230000033228 biological regulation Effects 0.000 description 2
• 239000002775 capsule Substances 0.000 description 2
• 239000000969 carrier Substances 0.000 description 2
• 238000004113 cell culture Methods 0.000 description 2
• OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 2
• 210000000349 chromosome Anatomy 0.000 description 2
• 238000000749 co-immunoprecipitation Methods 0.000 description 2
• 239000002299 complementary DNA Substances 0.000 description 2
• 230000009260 cross reactivity Effects 0.000 description 2
• 238000001514 detection method Methods 0.000 description 2
• 238000011161 development Methods 0.000 description 2
• 239000003085 diluting agent Substances 0.000 description 2
• 239000002612 dispersion medium Substances 0.000 description 2
• PDXPRWCJESNIIT-UHFFFAOYSA-N ethyl 1h-indole-5-carboxylate Chemical compound CCOC(=O)C1=CC=C2NC=CC2=C1 PDXPRWCJESNIIT-UHFFFAOYSA-N 0.000 description 2
• JZLZVIJITPGHLC-UHFFFAOYSA-N ethyl 3-(4-fluorobenzoyl)-1,1-dimethyl-2,6,7,8,9,10-hexahydroazepino[4,5-b]indole-5-carboxylate Chemical compound C1C(C)(C)C=2C=3CCCCC=3NC=2C(C(=O)OCC)=CN1C(=O)C1=CC=C(F)C=C1 JZLZVIJITPGHLC-UHFFFAOYSA-N 0.000 description 2
• 125000004494 ethyl ester group Chemical group 0.000 description 2
• 238000002474 experimental method Methods 0.000 description 2
• 230000002349 favourable effect Effects 0.000 description 2
• 230000006870 function Effects 0.000 description 2
• 108020001507 fusion proteins Proteins 0.000 description 2
• 102000037865 fusion proteins Human genes 0.000 description 2
• 235000011187 glycerol Nutrition 0.000 description 2
• 230000036541 health Effects 0.000 description 2
• 208000006454 hepatitis Diseases 0.000 description 2
• 238000001114 immunoprecipitation Methods 0.000 description 2
• 230000002757 inflammatory effect Effects 0.000 description 2
• 230000015788 innate immune response Effects 0.000 description 2
• 229940047124 interferons Drugs 0.000 description 2
• 238000007912 intraperitoneal administration Methods 0.000 description 2
• 108020001756 ligand binding domains Proteins 0.000 description 2
• 239000003550 marker Substances 0.000 description 2
• 230000004060 metabolic process Effects 0.000 description 2
• 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
• 208000008338 non-alcoholic fatty liver disease Diseases 0.000 description 2
• 206010053219 non-alcoholic steatohepatitis Diseases 0.000 description 2
• 239000002777 nucleoside Substances 0.000 description 2
• 229940127073 nucleoside analogue Drugs 0.000 description 2
• 239000002773 nucleotide Substances 0.000 description 2
• 125000003729 nucleotide group Chemical class 0.000 description 2
• 238000007911 parenteral administration Methods 0.000 description 2
• 239000004031 partial agonist Substances 0.000 description 2
• 229920001223 polyethylene glycol Polymers 0.000 description 2
• 230000002265 prevention Effects 0.000 description 2
• 230000002035 prolonged effect Effects 0.000 description 2
• 238000011002 quantification Methods 0.000 description 2
• 229940044601 receptor agonist Drugs 0.000 description 2
• 239000000018 receptor agonist Substances 0.000 description 2
• 102000027483 retinoid hormone receptors Human genes 0.000 description 2
• 108091008679 retinoid hormone receptors Proteins 0.000 description 2
• 238000003757 reverse transcription PCR Methods 0.000 description 2
• 238000012216 screening Methods 0.000 description 2
• 150000003384 small molecules Chemical class 0.000 description 2
• 239000001488 sodium phosphate Substances 0.000 description 2
• JAJWGJBVLPIOOH-IZYKLYLVSA-M sodium taurocholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 JAJWGJBVLPIOOH-IZYKLYLVSA-M 0.000 description 2
• 239000002904 solvent Substances 0.000 description 2
• 239000008174 sterile solution Substances 0.000 description 2
• 238000003860 storage Methods 0.000 description 2
• 239000004094 surface-active agent Substances 0.000 description 2
• 239000003826 tablet Substances 0.000 description 2
• 230000008685 targeting Effects 0.000 description 2
• GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
• 208000001072 type 2 diabetes mellitus Diseases 0.000 description 2
• 238000001262 western blot Methods 0.000 description 2
• CRDAMVZIKSXKFV-FBXUGWQNSA-N (2-cis,6-cis)-farnesol Chemical compound CC(C)=CCC\C(C)=C/CC\C(C)=C/CO CRDAMVZIKSXKFV-FBXUGWQNSA-N 0.000 description 1
• 239000000260 (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol Substances 0.000 description 1
• ONOPKLTVAKTMQL-UHFFFAOYSA-N 1-(4-fluorobenzoyl)-1,2,3,6-tetrahydroazepino[4,5-b]indole-2,5-dicarboxylic acid Chemical compound OC(=O)C1NC=C(C(O)=O)C=2NC3=CC=CC=C3C=2C1C(=O)C1=CC=C(F)C=C1 ONOPKLTVAKTMQL-UHFFFAOYSA-N 0.000 description 1
• IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
• YKBGVTZYEHREMT-KVQBGUIXSA-N 2'-deoxyguanosine Chemical class C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](CO)O1 YKBGVTZYEHREMT-KVQBGUIXSA-N 0.000 description 1
• MPKISXFIMCWMLP-UHFFFAOYSA-N 2,3-dichloro-1-oxidopyridin-1-ium Chemical compound [O-][N+]1=CC=CC(Cl)=C1Cl MPKISXFIMCWMLP-UHFFFAOYSA-N 0.000 description 1
• DAPVXLPFTYNORR-UHFFFAOYSA-N 2-(6-chloro-5-fluoro-2-pyridin-2-ylbenzimidazol-1-yl)-n,2-dicyclohexylacetamide Chemical compound C1CCCCC1C(C(=O)NC1CCCCC1)N1C=2C=C(Cl)C(F)=CC=2N=C1C1=CC=CC=N1 DAPVXLPFTYNORR-UHFFFAOYSA-N 0.000 description 1
• REERTFSPUHJHCT-UHFFFAOYSA-N 2-[2-(2,3-dimethoxyphenyl)benzimidazol-1-yl]-4-methyl-n-propan-2-ylpentanamide Chemical compound COC1=CC=CC(C=2N(C3=CC=CC=C3N=2)C(CC(C)C)C(=O)NC(C)C)=C1OC REERTFSPUHJHCT-UHFFFAOYSA-N 0.000 description 1
• WHEBEUVWXOQSAY-UHFFFAOYSA-N 2-[2-(2-aminopyridin-3-yl)benzimidazol-1-yl]-n,2-dicyclohexylacetamide Chemical compound NC1=NC=CC=C1C1=NC2=CC=CC=C2N1C(C(=O)NC1CCCCC1)C1CCCCC1 WHEBEUVWXOQSAY-UHFFFAOYSA-N 0.000 description 1
• MEAJMISBOOCGEH-UHFFFAOYSA-N 2-[2-(3-chlorophenyl)benzimidazol-1-yl]-n-cyclohexyl-4-methylpentanamide Chemical compound C=1C=CC(Cl)=CC=1C1=NC2=CC=CC=C2N1C(CC(C)C)C(=O)NC1CCCCC1 MEAJMISBOOCGEH-UHFFFAOYSA-N 0.000 description 1
• HIUARBSTSPPJME-UHFFFAOYSA-N 2-[2-(3-cyanophenyl)benzimidazol-1-yl]-n-cyclohexyl-4-methylpentanamide Chemical compound C=1C=CC(C#N)=CC=1C1=NC2=CC=CC=C2N1C(CC(C)C)C(=O)NC1CCCCC1 HIUARBSTSPPJME-UHFFFAOYSA-N 0.000 description 1
• MNMBVJSKIWGQSA-UHFFFAOYSA-N 2-[2-(3-cyanophenyl)benzimidazol-1-yl]-n-propan-2-ylhexanamide Chemical compound N=1C2=CC=CC=C2N(C(C(=O)NC(C)C)CCCC)C=1C1=CC=CC(C#N)=C1 MNMBVJSKIWGQSA-UHFFFAOYSA-N 0.000 description 1
• NXVQEZNRSIOXDQ-UHFFFAOYSA-N 2-[2-(4-acetylphenyl)benzimidazol-1-yl]-n-cyclohexyl-4-methylpentanamide Chemical compound C=1C=C(C(C)=O)C=CC=1C1=NC2=CC=CC=C2N1C(CC(C)C)C(=O)NC1CCCCC1 NXVQEZNRSIOXDQ-UHFFFAOYSA-N 0.000 description 1
• LWLWISAYOFFQJV-UHFFFAOYSA-N 2-[2-(4-acetylphenyl)benzimidazol-1-yl]-n-propan-2-ylhexanamide Chemical compound N=1C2=CC=CC=C2N(C(C(=O)NC(C)C)CCCC)C=1C1=CC=C(C(C)=O)C=C1 LWLWISAYOFFQJV-UHFFFAOYSA-N 0.000 description 1
• AUUGNDXEXIHCNP-UHFFFAOYSA-N 2-[2-(4-aminophenyl)benzimidazol-1-yl]-n-cyclohexyl-4-methylpentanamide Chemical compound C=1C=C(N)C=CC=1C1=NC2=CC=CC=C2N1C(CC(C)C)C(=O)NC1CCCCC1 AUUGNDXEXIHCNP-UHFFFAOYSA-N 0.000 description 1
• NZYWLQYWDJJMDS-UHFFFAOYSA-N 2-[2-(4-chlorophenyl)-5-fluorobenzimidazol-1-yl]-n,2-dicyclohexylacetamide Chemical compound C=1C=C(Cl)C=CC=1C1=NC2=CC(F)=CC=C2N1C(C(=O)NC1CCCCC1)C1CCCCC1 NZYWLQYWDJJMDS-UHFFFAOYSA-N 0.000 description 1
• DGRXQTCUKBEVGI-UHFFFAOYSA-N 2-[2-(4-chlorophenyl)benzimidazol-1-yl]-n-cyclohexyl-4-methylpentanamide Chemical compound C=1C=C(Cl)C=CC=1C1=NC2=CC=CC=C2N1C(CC(C)C)C(=O)NC1CCCCC1 DGRXQTCUKBEVGI-UHFFFAOYSA-N 0.000 description 1
• WGYWRLCAEVGLML-UHFFFAOYSA-N 2-[2-(4-hydroxyphenyl)benzimidazol-1-yl]-N-propan-2-ylpentanamide Chemical compound N=1C2=CC=CC=C2N(C(C(=O)NC(C)C)CCC)C=1C1=CC=C(O)C=C1 WGYWRLCAEVGLML-UHFFFAOYSA-N 0.000 description 1
• PORUMOZHVYQHDZ-UHFFFAOYSA-N 2-[4-(4-bromo-2-carboxy-1-benzofuran-5-yl)piperazine-1-carbonyl]pyrrolidine-1-carboxylic acid Chemical compound BrC1=C(C=CC2=C1C=C(O2)C(=O)O)N2CCN(CC2)C(=O)C2N(CCC2)C(=O)O PORUMOZHVYQHDZ-UHFFFAOYSA-N 0.000 description 1
• IDVWFRRQOFXIBN-UHFFFAOYSA-N 2-[6-chloro-2-(4-chlorophenyl)-5-fluorobenzimidazol-1-yl]-n,2-dicyclohexylacetamide Chemical compound C1CCCCC1C(C(=O)NC1CCCCC1)N1C=2C=C(Cl)C(F)=CC=2N=C1C1=CC=C(Cl)C=C1 IDVWFRRQOFXIBN-UHFFFAOYSA-N 0.000 description 1
• YTQLUZBGWZQARS-UHFFFAOYSA-N 2-[[4-[2-[2-chloro-4-[[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]methoxy]phenyl]cyclopropyl]benzoyl]amino]acetic acid Chemical compound C1=CC(C(=O)NCC(=O)O)=CC=C1C1C(C=2C(=CC(OCC3=C(ON=C3C=3C(=CC=CC=3Cl)Cl)C3CC3)=CC=2)Cl)C1 YTQLUZBGWZQARS-UHFFFAOYSA-N 0.000 description 1
• 125000004174 2-benzimidazolyl group Chemical group [H]N1C(*)=NC2=C([H])C([H])=C([H])C([H])=C12 0.000 description 1
• VDBFBILXPPUEQT-UHFFFAOYSA-N 2-cyclobutyl-n-cyclohexyl-2-[2-(3,4-dichlorophenyl)-6-methoxybenzimidazol-1-yl]acetamide Chemical compound C1CCC1C(C(=O)NC1CCCCC1)N1C2=CC(OC)=CC=C2N=C1C1=CC=C(Cl)C(Cl)=C1 VDBFBILXPPUEQT-UHFFFAOYSA-N 0.000 description 1
• OXRCIXHTUHZNRY-UHFFFAOYSA-N 2-cyclopentylacetamide Chemical compound NC(=O)CC1CCCC1 OXRCIXHTUHZNRY-UHFFFAOYSA-N 0.000 description 1
• 125000006290 2-hydroxybenzyl group Chemical group [H]OC1=C(C([H])=C([H])C([H])=C1[H])C([H])([H])* 0.000 description 1
• 125000000389 2-pyrrolyl group Chemical group [H]N1C([*])=C([H])C([H])=C1[H] 0.000 description 1
• 125000004211 3,5-difluorophenyl group Chemical group [H]C1=C(F)C([H])=C(*)C([H])=C1F 0.000 description 1
• LAQUKKNQRFHMNT-UHFFFAOYSA-N 3-(3,4-difluorobenzoyl)-9-fluoro-1,1-dimethyl-n-propan-2-yl-2,6-dihydroazepino[4,5-b]indole-5-carboxamide Chemical compound C1C(C)(C)C(C2=CC(F)=CC=C2N2)=C2C(C(=O)NC(C)C)=CN1C(=O)C1=CC=C(F)C(F)=C1 LAQUKKNQRFHMNT-UHFFFAOYSA-N 0.000 description 1
• FLHKQVNMCNLAOR-UHFFFAOYSA-N 3-(4-fluorobenzoyl)-1,1-dimethyl-n-propan-2-yl-2,6-dihydroazepino[4,5-b]indole-5-carboxamide Chemical compound C1C(C)(C)C(C2=CC=CC=C2N2)=C2C(C(=O)NC(C)C)=CN1C(=O)C1=CC=C(F)C=C1 FLHKQVNMCNLAOR-UHFFFAOYSA-N 0.000 description 1
• OXWIZSQXZOTTNH-UHFFFAOYSA-N 3-(4-fluorobenzoyl)-2,6-dihydro-1h-azepino[4,5-b]indole-5-carboxylic acid Chemical compound C1CC(C2=CC=CC=C2N2)=C2C(C(=O)O)=CN1C(=O)C1=CC=C(F)C=C1 OXWIZSQXZOTTNH-UHFFFAOYSA-N 0.000 description 1
• BECQTTMMUHTDGU-UHFFFAOYSA-N 3-[2-[2-chloro-4-[[3-(2,6-dichlorophenyl)-5-propan-2-yltriazol-4-yl]methoxy]phenyl]cyclopropyl]benzoic acid Chemical compound CC(C)C=1N=NN(C=2C(=CC=CC=2Cl)Cl)C=1COC(C=C1Cl)=CC=C1C1CC1C1=CC=CC(C(O)=O)=C1 BECQTTMMUHTDGU-UHFFFAOYSA-N 0.000 description 1
• WCUXUCYXDBLAQW-UHFFFAOYSA-N 3-[2-[2-chloro-4-[[5-cyclopropyl-3-(3,5-dichloropyridin-4-yl)-1,2-oxazol-4-yl]methoxy]phenyl]cyclopropyl]benzoic acid Chemical compound OC(=O)C1=CC=CC(C2C(C2)C=2C(=CC(OCC3=C(ON=C3C=3C(=CN=CC=3Cl)Cl)C3CC3)=CC=2)Cl)=C1 WCUXUCYXDBLAQW-UHFFFAOYSA-N 0.000 description 1
• PDOUFQOWISOLIC-UHFFFAOYSA-N 3-[3-[2-chloro-4-[[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]methoxy]phenyl]-3-hydroxyazetidin-1-yl]benzoic acid Chemical compound OC(=O)C1=CC=CC(N2CC(O)(C2)C=2C(=CC(OCC=3C(=NOC=3C3CC3)C=3C(=CC=CC=3Cl)Cl)=CC=2)Cl)=C1 PDOUFQOWISOLIC-UHFFFAOYSA-N 0.000 description 1
• BLUPXUIEWBLQAV-UHFFFAOYSA-N 3-[3-[2-chloro-4-[[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]methoxy]phenyl]-3-hydroxycyclobutyl]benzoic acid Chemical compound OC(=O)C1=CC=CC(C2CC(O)(C2)C=2C(=CC(OCC=3C(=NOC=3C3CC3)C=3C(=CC=CC=3Cl)Cl)=CC=2)Cl)=C1 BLUPXUIEWBLQAV-UHFFFAOYSA-N 0.000 description 1
• DSPGOYYODRWIIO-UHFFFAOYSA-N 4-(4-bromo-2-carboxy-1-benzofuran-5-yl)-1,4-diazepane-1-carboxylic acid Chemical compound BrC1=C(C=CC2=C1C=C(O2)C(=O)O)N1CCN(CCC1)C(=O)O DSPGOYYODRWIIO-UHFFFAOYSA-N 0.000 description 1
• QHQXZFJTBGVHBC-UHFFFAOYSA-N 4-[2-[2-chloro-4-[[3-(2,6-dichlorophenyl)-5-(2-hydroxypropan-2-yl)-1,2-oxazol-4-yl]methoxy]phenyl]cyclopropyl]benzoic acid Chemical compound CC(C)(O)C=1ON=C(C=2C(=CC=CC=2Cl)Cl)C=1COC(C=C1Cl)=CC=C1C1CC1C1=CC=C(C(O)=O)C=C1 QHQXZFJTBGVHBC-UHFFFAOYSA-N 0.000 description 1
• HRRRVYPLQKAORH-UHFFFAOYSA-N 4-[2-[2-chloro-4-[[5-(2,6-dichlorophenyl)-3-propan-2-yltriazol-4-yl]methoxy]phenyl]cyclopropyl]benzoic acid Chemical compound CC(C)N1N=NC(C=2C(=CC=CC=2Cl)Cl)=C1COC(C=C1Cl)=CC=C1C1CC1C1=CC=C(C(O)=O)C=C1 HRRRVYPLQKAORH-UHFFFAOYSA-N 0.000 description 1
• TZOWHCMZLPJVMM-UHFFFAOYSA-N 4-[2-[2-chloro-4-[[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]methoxy]phenyl]cyclopropyl]-2,6-dimethylbenzoic acid Chemical compound CC1=C(C(O)=O)C(C)=CC(C2C(C2)C=2C(=CC(OCC3=C(ON=C3C=3C(=CC=CC=3Cl)Cl)C3CC3)=CC=2)Cl)=C1 TZOWHCMZLPJVMM-UHFFFAOYSA-N 0.000 description 1
• RTVHCMXNBNQUNY-UHFFFAOYSA-N 4-[2-[2-chloro-4-[[5-cyclopropyl-3-[2-(trifluoromethoxy)phenyl]-1,2-oxazol-4-yl]methoxy]phenyl]cyclopropyl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C1C(C=2C(=CC(OCC3=C(ON=C3C=3C(=CC=CC=3)OC(F)(F)F)C3CC3)=CC=2)Cl)C1 RTVHCMXNBNQUNY-UHFFFAOYSA-N 0.000 description 1
• QHDIUVPBUZOQJN-UHFFFAOYSA-N 4-[3-[2-chloro-4-[[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]methoxy]phenyl]-3-hydroxycyclobutyl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1C1CC(O)(C=2C(=CC(OCC=3C(=NOC=3C3CC3)C=3C(=CC=CC=3Cl)Cl)=CC=2)Cl)C1 QHDIUVPBUZOQJN-UHFFFAOYSA-N 0.000 description 1
• BRGZVODKWYXORA-UHFFFAOYSA-N 4-[[3-chloro-4-[2-[4-(2h-tetrazol-5-yl)phenyl]cyclopropyl]phenoxy]methyl]-5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazole Chemical compound ClC1=CC=CC(Cl)=C1C1=NOC(C2CC2)=C1COC(C=C1Cl)=CC=C1C1C(C=2C=CC(=CC=2)C=2NN=NN=2)C1 BRGZVODKWYXORA-UHFFFAOYSA-N 0.000 description 1
• KNWXWQGSCZVUGX-UHFFFAOYSA-N 4-[[[6-[[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]methoxy]-2-(trifluoromethyl)pyridin-3-yl]-methylamino]methyl]benzoic acid Chemical compound C=1C=C(OCC=2C(=NOC=2C2CC2)C=2C(=CC=CC=2Cl)Cl)N=C(C(F)(F)F)C=1N(C)CC1=CC=C(C(O)=O)C=C1 KNWXWQGSCZVUGX-UHFFFAOYSA-N 0.000 description 1
• VHPYWWWYZZGHDU-UHFFFAOYSA-N 4-bromo-5-(3,4-dihydro-1h-isoquinolin-2-yl)-1-benzofuran-2-carboxylic acid Chemical compound C1CC2=CC=CC=C2CN1C1=CC=C(OC(C(=O)O)=C2)C2=C1Br VHPYWWWYZZGHDU-UHFFFAOYSA-N 0.000 description 1
• HZYNGWBTYAZHJS-UHFFFAOYSA-N 4-bromo-5-(4-pyridin-2-yloxypiperidin-1-yl)-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Br)C=1N(CC1)CCC1OC1=CC=CC=N1 HZYNGWBTYAZHJS-UHFFFAOYSA-N 0.000 description 1
• AXJROUWDPMFTTD-UHFFFAOYSA-N 4-bromo-5-[4-(2,3-dichlorobenzoyl)piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Br)C=1N(CC1)CCN1C(=O)C1=CC=CC(Cl)=C1Cl AXJROUWDPMFTTD-UHFFFAOYSA-N 0.000 description 1
• JVHPVQFWLKSUMM-UHFFFAOYSA-N 4-bromo-5-[4-(2,3-dichlorophenyl)sulfonylpiperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Br)C=1N(CC1)CCN1S(=O)(=O)C1=CC=CC(Cl)=C1Cl JVHPVQFWLKSUMM-UHFFFAOYSA-N 0.000 description 1
• XNBIZRZVOMEYEP-UHFFFAOYSA-N 4-bromo-5-[4-(2,5-dichlorobenzoyl)piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Br)C=1N(CC1)CCN1C(=O)C1=CC(Cl)=CC=C1Cl XNBIZRZVOMEYEP-UHFFFAOYSA-N 0.000 description 1
• MEEKANDNUDGZBS-UHFFFAOYSA-N 4-bromo-5-[4-(2,5-dichlorophenyl)sulfonylpiperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Br)C=1N(CC1)CCN1S(=O)(=O)C1=CC(Cl)=CC=C1Cl MEEKANDNUDGZBS-UHFFFAOYSA-N 0.000 description 1
• OMOOAVJKWWTGLS-UHFFFAOYSA-N 4-bromo-5-[4-(2,6-dichlorobenzoyl)-1,4-diazepan-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Br)C=1N(CC1)CCCN1C(=O)C1=C(Cl)C=CC=C1Cl OMOOAVJKWWTGLS-UHFFFAOYSA-N 0.000 description 1
• HBSQZCJVXLLLII-UHFFFAOYSA-N 4-bromo-5-[4-(2,6-dichlorobenzoyl)piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Br)C=1N(CC1)CCN1C(=O)C1=C(Cl)C=CC=C1Cl HBSQZCJVXLLLII-UHFFFAOYSA-N 0.000 description 1
• QNPCXBPRESIUTF-UHFFFAOYSA-N 4-bromo-5-[4-(2,6-dichlorophenyl)sulfonylpiperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Br)C=1N(CC1)CCN1S(=O)(=O)C1=C(Cl)C=CC=C1Cl QNPCXBPRESIUTF-UHFFFAOYSA-N 0.000 description 1
• GKYZXKQXZUJDHL-UHFFFAOYSA-N 4-bromo-5-[4-(2,6-dichlorophenyl)sulfonylpiperazin-1-yl]-n-[2-(dimethylamino)ethyl]-1-benzofuran-2-carboxamide Chemical compound C=1C=C2OC(C(=O)NCCN(C)C)=CC2=C(Br)C=1N(CC1)CCN1S(=O)(=O)C1=C(Cl)C=CC=C1Cl GKYZXKQXZUJDHL-UHFFFAOYSA-N 0.000 description 1
• ZUCSLYGDUXLFCF-UHFFFAOYSA-N 4-bromo-5-[4-(2-chlorophenyl)sulfonylpiperazin-1-yl]-1-benzofuran-2-carboxamide Chemical compound C=1C=C2OC(C(=O)N)=CC2=C(Br)C=1N(CC1)CCN1S(=O)(=O)C1=CC=CC=C1Cl ZUCSLYGDUXLFCF-UHFFFAOYSA-N 0.000 description 1
• FXZBZWCRHPUSGB-UHFFFAOYSA-N 4-bromo-5-[4-(2-chlorophenyl)sulfonylpiperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Br)C=1N(CC1)CCN1S(=O)(=O)C1=CC=CC=C1Cl FXZBZWCRHPUSGB-UHFFFAOYSA-N 0.000 description 1
• YVWGWWWTJFJMKG-UHFFFAOYSA-N 4-bromo-5-[4-(2-chlorophenyl)sulfonylpiperazin-1-yl]-n-(2-methoxyethyl)-1-benzofuran-2-carboxamide Chemical compound C=1C=C2OC(C(=O)NCCOC)=CC2=C(Br)C=1N(CC1)CCN1S(=O)(=O)C1=CC=CC=C1Cl YVWGWWWTJFJMKG-UHFFFAOYSA-N 0.000 description 1
• ZPCXXVSOGZODOV-UHFFFAOYSA-N 4-bromo-5-[4-(2-fluorophenyl)sulfonylpiperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Br)C=1N(CC1)CCN1S(=O)(=O)C1=CC=CC=C1F ZPCXXVSOGZODOV-UHFFFAOYSA-N 0.000 description 1
• WGQBIRXSWAANHX-UHFFFAOYSA-N 4-bromo-5-[4-(2-methyl-1h-benzimidazole-4-carbonyl)piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C1=C2OC(C(O)=O)=CC2=C(Br)C(N2CCN(CC2)C(=O)C2=C3N=C(NC3=CC=C2)C)=C1 WGQBIRXSWAANHX-UHFFFAOYSA-N 0.000 description 1
• BJFBMDRGNPQEAT-UHFFFAOYSA-N 4-bromo-5-[4-(3,5-dichlorobenzoyl)piperazin-1-yl]-1-benzofuran-2-carboxamide Chemical compound C=1C=C2OC(C(=O)N)=CC2=C(Br)C=1N(CC1)CCN1C(=O)C1=CC(Cl)=CC(Cl)=C1 BJFBMDRGNPQEAT-UHFFFAOYSA-N 0.000 description 1
• PZGFWUJMMOQZQB-UHFFFAOYSA-N 4-bromo-5-[4-(3,5-dichlorobenzoyl)piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Br)C=1N(CC1)CCN1C(=O)C1=CC(Cl)=CC(Cl)=C1 PZGFWUJMMOQZQB-UHFFFAOYSA-N 0.000 description 1
• PPZKKMWZDRKIJK-UHFFFAOYSA-N 4-bromo-5-[4-(3-chlorobenzoyl)piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Br)C=1N(CC1)CCN1C(=O)C1=CC=CC(Cl)=C1 PPZKKMWZDRKIJK-UHFFFAOYSA-N 0.000 description 1
• DIJWIJFWGVEBHF-UHFFFAOYSA-N 4-bromo-5-[4-(3-chlorophenoxy)piperidin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Br)C=1N(CC1)CCC1OC1=CC=CC(Cl)=C1 DIJWIJFWGVEBHF-UHFFFAOYSA-N 0.000 description 1
• QJFUFUFTVCCLQG-UHFFFAOYSA-N 4-bromo-5-[4-(3-chlorophenyl)sulfonylpiperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Br)C=1N(CC1)CCN1S(=O)(=O)C1=CC=CC(Cl)=C1 QJFUFUFTVCCLQG-UHFFFAOYSA-N 0.000 description 1
• GNHSHMAPHAIYDI-UHFFFAOYSA-N 4-bromo-5-[4-(3-cyanophenyl)sulfonylpiperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Br)C=1N(CC1)CCN1S(=O)(=O)C1=CC=CC(C#N)=C1 GNHSHMAPHAIYDI-UHFFFAOYSA-N 0.000 description 1
• RMZWZAXDOGJKTD-UHFFFAOYSA-N 4-bromo-5-[4-(3-fluorophenyl)sulfonylpiperazin-1-yl]-1-benzofuran-2-carboxamide Chemical compound C=1C=C2OC(C(=O)N)=CC2=C(Br)C=1N(CC1)CCN1S(=O)(=O)C1=CC=CC(F)=C1 RMZWZAXDOGJKTD-UHFFFAOYSA-N 0.000 description 1
• LZQICQDCCAOVDE-UHFFFAOYSA-N 4-bromo-5-[4-(3-fluorophenyl)sulfonylpiperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Br)C=1N(CC1)CCN1S(=O)(=O)C1=CC=CC(F)=C1 LZQICQDCCAOVDE-UHFFFAOYSA-N 0.000 description 1
• UPDXLSKCJBXOLH-UHFFFAOYSA-N 4-bromo-5-[4-(3-methoxybenzoyl)piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound COC1=CC=CC(C(=O)N2CCN(CC2)C=2C(=C3C=C(OC3=CC=2)C(O)=O)Br)=C1 UPDXLSKCJBXOLH-UHFFFAOYSA-N 0.000 description 1
• PNGYBZVLLJJMGR-UHFFFAOYSA-N 4-bromo-5-[4-(3-methoxyphenyl)sulfonylpiperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound COC1=CC=CC(S(=O)(=O)N2CCN(CC2)C=2C(=C3C=C(OC3=CC=2)C(O)=O)Br)=C1 PNGYBZVLLJJMGR-UHFFFAOYSA-N 0.000 description 1
• SNHKOVSPJQJBQE-UHFFFAOYSA-N 4-bromo-5-[4-(4-chlorophenoxy)piperidin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Br)C=1N(CC1)CCC1OC1=CC=C(Cl)C=C1 SNHKOVSPJQJBQE-UHFFFAOYSA-N 0.000 description 1
• AWFWHOTXYKBJOE-UHFFFAOYSA-N 4-bromo-5-[4-(4-chlorophenyl)sulfonylpiperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Br)C=1N(CC1)CCN1S(=O)(=O)C1=CC=C(Cl)C=C1 AWFWHOTXYKBJOE-UHFFFAOYSA-N 0.000 description 1
• STDQPCVYAFEQOB-UHFFFAOYSA-N 4-bromo-5-[4-(4-methoxyphenyl)sulfonylpiperazin-1-yl]-1-benzofuran-2-carboxamide Chemical compound C1=CC(OC)=CC=C1S(=O)(=O)N1CCN(C=2C(=C3C=C(OC3=CC=2)C(N)=O)Br)CC1 STDQPCVYAFEQOB-UHFFFAOYSA-N 0.000 description 1
• GGWRZDHSNHYZMO-UHFFFAOYSA-N 4-bromo-5-[4-(4-methoxyphenyl)sulfonylpiperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C1=CC(OC)=CC=C1S(=O)(=O)N1CCN(C=2C(=C3C=C(OC3=CC=2)C(O)=O)Br)CC1 GGWRZDHSNHYZMO-UHFFFAOYSA-N 0.000 description 1
• SFIDRQDIDVJSQW-UHFFFAOYSA-N 4-bromo-5-[4-(pyridin-3-ylmethyl)piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Br)C=1N(CC1)CCN1CC1=CC=CN=C1 SFIDRQDIDVJSQW-UHFFFAOYSA-N 0.000 description 1
• KTERSGOVINBBAU-UHFFFAOYSA-N 4-bromo-5-[4-(pyridin-4-ylmethyl)piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Br)C=1N(CC1)CCN1CC1=CC=NC=C1 KTERSGOVINBBAU-UHFFFAOYSA-N 0.000 description 1
• QSSURRWELOWNJN-UHFFFAOYSA-N 4-bromo-5-[4-(pyrrolidine-1-carbonyl)piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Br)C=1N(CC1)CCN1C(=O)N1CCCC1 QSSURRWELOWNJN-UHFFFAOYSA-N 0.000 description 1
• ARROYWRUGSBZCD-UHFFFAOYSA-N 4-bromo-5-[4-(pyrrolidine-2-carbonyl)piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Br)C=1N(CC1)CCN1C(=O)C1CCCN1 ARROYWRUGSBZCD-UHFFFAOYSA-N 0.000 description 1
• NBWJUYQSJPVCQS-UHFFFAOYSA-N 4-bromo-5-[4-[(2,4-dichlorophenyl)methyl]piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Br)C=1N(CC1)CCN1CC1=CC=C(Cl)C=C1Cl NBWJUYQSJPVCQS-UHFFFAOYSA-N 0.000 description 1
• KFGHTASUDKPLAA-UHFFFAOYSA-N 4-bromo-5-[4-[(2,5-dichlorophenyl)methyl]piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Br)C=1N(CC1)CCN1CC1=CC(Cl)=CC=C1Cl KFGHTASUDKPLAA-UHFFFAOYSA-N 0.000 description 1
• NKAKIFLPZJADTK-UHFFFAOYSA-N 4-bromo-5-[4-[(2,6-dichlorophenyl)methyl]piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Br)C=1N(CC1)CCN1CC1=C(Cl)C=CC=C1Cl NKAKIFLPZJADTK-UHFFFAOYSA-N 0.000 description 1
• BYQNZDLHJDUHBQ-UHFFFAOYSA-N 4-bromo-5-[4-[(2-chloro-6-fluorophenyl)methyl]piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Br)C=1N(CC1)CCN1CC1=C(F)C=CC=C1Cl BYQNZDLHJDUHBQ-UHFFFAOYSA-N 0.000 description 1
• FCZWRZJWNFWPFX-UHFFFAOYSA-N 4-bromo-5-[4-[(2-chlorophenyl)methyl]piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Br)C=1N(CC1)CCN1CC1=CC=CC=C1Cl FCZWRZJWNFWPFX-UHFFFAOYSA-N 0.000 description 1
• PKOCVLLCYHTMAY-UHFFFAOYSA-N 4-bromo-5-[4-[(2-fluorophenyl)methyl]piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Br)C=1N(CC1)CCN1CC1=CC=CC=C1F PKOCVLLCYHTMAY-UHFFFAOYSA-N 0.000 description 1
• XUGTYVUYZCCVIR-UHFFFAOYSA-N 4-bromo-5-[4-[(2-hydroxynaphthalen-1-yl)methyl]piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C1=CC=C2C(CN3CCN(CC3)C=3C(Br)=C4C=C(OC4=CC=3)C(=O)O)=C(O)C=CC2=C1 XUGTYVUYZCCVIR-UHFFFAOYSA-N 0.000 description 1
• JQHRVZUOCSJEKH-UHFFFAOYSA-N 4-bromo-5-[4-[(2-methylpropan-2-yl)oxycarbonyl]piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1C1=CC=C(OC(=C2)C(O)=O)C2=C1Br JQHRVZUOCSJEKH-UHFFFAOYSA-N 0.000 description 1
• RHXLMTKVEDZOMW-UHFFFAOYSA-N 4-bromo-5-[4-[(3,5-dichlorophenyl)methyl]piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Br)C=1N(CC1)CCN1CC1=CC(Cl)=CC(Cl)=C1 RHXLMTKVEDZOMW-UHFFFAOYSA-N 0.000 description 1
• YAJCHNKVBUMNBV-UHFFFAOYSA-N 4-bromo-5-[4-[(3,5-difluorophenyl)methyl]piperazin-1-yl]-1-benzofuran-2-carboxamide Chemical compound C=1C=C2OC(C(=O)N)=CC2=C(Br)C=1N(CC1)CCN1CC1=CC(F)=CC(F)=C1 YAJCHNKVBUMNBV-UHFFFAOYSA-N 0.000 description 1
• YEJCIFRMIJJZDE-UHFFFAOYSA-N 4-bromo-5-[4-[(3,5-dimethoxyphenyl)methyl]piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound COC1=CC(OC)=CC(CN2CCN(CC2)C=2C(=C3C=C(OC3=CC=2)C(O)=O)Br)=C1 YEJCIFRMIJJZDE-UHFFFAOYSA-N 0.000 description 1
• XFQVWFUSNNNQFZ-UHFFFAOYSA-N 4-bromo-5-[4-[(3-chlorophenyl)methoxy]piperidin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Br)C=1N(CC1)CCC1OCC1=CC=CC(Cl)=C1 XFQVWFUSNNNQFZ-UHFFFAOYSA-N 0.000 description 1
• YIXRTYAFDRDHGA-UHFFFAOYSA-N 4-bromo-5-[4-[(3-chlorophenyl)methylsulfonyl]piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Br)C=1N(CC1)CCN1S(=O)(=O)CC1=CC=CC(Cl)=C1 YIXRTYAFDRDHGA-UHFFFAOYSA-N 0.000 description 1
• OHSFBHBOGVNYFY-UHFFFAOYSA-N 4-bromo-5-[4-[(3-ethoxyphenyl)methyl]piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound CCOC1=CC=CC(CN2CCN(CC2)C=2C(=C3C=C(OC3=CC=2)C(O)=O)Br)=C1 OHSFBHBOGVNYFY-UHFFFAOYSA-N 0.000 description 1
• ZIMBNBXQSNQEHS-UHFFFAOYSA-N 4-bromo-5-[4-[(3-fluorophenyl)methyl]piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Br)C=1N(CC1)CCN1CC1=CC=CC(F)=C1 ZIMBNBXQSNQEHS-UHFFFAOYSA-N 0.000 description 1
• GZRYKHHHBOCHCE-UHFFFAOYSA-N 4-bromo-5-[4-[(3-phenoxyphenyl)methyl]piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Br)C=1N(CC1)CCN1CC(C=1)=CC=CC=1OC1=CC=CC=C1 GZRYKHHHBOCHCE-UHFFFAOYSA-N 0.000 description 1
• JKECAEUDBLAZQT-UHFFFAOYSA-N 4-bromo-5-[4-[(4-chlorophenyl)methyl-(cyclopropanecarbonyl)amino]piperidin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Br)C=1N(CC1)CCC1N(C(=O)C1CC1)CC1=CC=C(Cl)C=C1 JKECAEUDBLAZQT-UHFFFAOYSA-N 0.000 description 1
• CNWXAGRCDFPYRQ-UHFFFAOYSA-N 4-bromo-5-[4-[(4-chlorophenyl)methyl]piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Br)C=1N(CC1)CCN1CC1=CC=C(Cl)C=C1 CNWXAGRCDFPYRQ-UHFFFAOYSA-N 0.000 description 1
• GXZFAOOKJZRUOO-UHFFFAOYSA-N 4-bromo-5-[4-[(4-fluorophenyl)methyl]piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Br)C=1N(CC1)CCN1CC1=CC=C(F)C=C1 GXZFAOOKJZRUOO-UHFFFAOYSA-N 0.000 description 1
• HPHTVOQUHSIKIR-UHFFFAOYSA-N 4-bromo-5-[4-[(5-chlorothiophen-2-yl)methyl]piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Br)C=1N(CC1)CCN1CC1=CC=C(Cl)S1 HPHTVOQUHSIKIR-UHFFFAOYSA-N 0.000 description 1
• COXMCMRKMIQNLB-UHFFFAOYSA-N 4-bromo-5-[4-[2,4-dichloro-n-(cyclopropanecarbonyl)anilino]piperidin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Br)C=1N(CC1)CCC1N(C=1C(=CC(Cl)=CC=1)Cl)C(=O)C1CC1 COXMCMRKMIQNLB-UHFFFAOYSA-N 0.000 description 1
• WUKLUNKOZRLKCJ-UHFFFAOYSA-N 4-bromo-5-[4-[2-(trifluoromethyl)phenyl]sulfonylpiperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Br)C=1N(CC1)CCN1S(=O)(=O)C1=CC=CC=C1C(F)(F)F WUKLUNKOZRLKCJ-UHFFFAOYSA-N 0.000 description 1
• QBFITKBHABNOBV-UHFFFAOYSA-N 4-bromo-5-[4-[3-(trifluoromethoxy)benzoyl]piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Br)C=1N(CC1)CCN1C(=O)C1=CC=CC(OC(F)(F)F)=C1 QBFITKBHABNOBV-UHFFFAOYSA-N 0.000 description 1
• AFHNKQCXMNPDFX-UHFFFAOYSA-N 4-bromo-5-[4-[3-(trifluoromethyl)benzoyl]piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Br)C=1N(CC1)CCN1C(=O)C1=CC=CC(C(F)(F)F)=C1 AFHNKQCXMNPDFX-UHFFFAOYSA-N 0.000 description 1
• ULGGZPNHEMMUGG-UHFFFAOYSA-N 4-bromo-5-[4-[3-(trifluoromethyl)phenoxy]piperidin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Br)C=1N(CC1)CCC1OC1=CC=CC(C(F)(F)F)=C1 ULGGZPNHEMMUGG-UHFFFAOYSA-N 0.000 description 1
• CNNXSTYRFPFZJW-UHFFFAOYSA-N 4-bromo-5-[4-[3-(trifluoromethyl)phenyl]sulfonylpiperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Br)C=1N(CC1)CCN1S(=O)(=O)C1=CC=CC(C(F)(F)F)=C1 CNNXSTYRFPFZJW-UHFFFAOYSA-N 0.000 description 1
• LVSXVZKBBNRLCZ-UHFFFAOYSA-N 4-bromo-5-[4-[4-(trifluoromethyl)phenoxy]piperidin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Br)C=1N(CC1)CCC1OC1=CC=C(C(F)(F)F)C=C1 LVSXVZKBBNRLCZ-UHFFFAOYSA-N 0.000 description 1
• VLQMHVUISYIYBD-UHFFFAOYSA-N 4-bromo-5-[4-[4-(trifluoromethyl)pyrimidin-2-yl]oxypiperidin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Br)C=1N(CC1)CCC1OC1=NC=CC(C(F)(F)F)=N1 VLQMHVUISYIYBD-UHFFFAOYSA-N 0.000 description 1
• RPHBGFWAVXTERG-UHFFFAOYSA-N 4-bromo-5-[4-[5-(trifluoromethyl)pyridin-2-yl]oxypiperidin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Br)C=1N(CC1)CCC1OC1=CC=C(C(F)(F)F)C=N1 RPHBGFWAVXTERG-UHFFFAOYSA-N 0.000 description 1
• AHZARNDGFDIANI-UHFFFAOYSA-N 4-bromo-5-[4-[[2-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Br)C=1N(CC1)CCN1CC1=CC=CC=C1C(F)(F)F AHZARNDGFDIANI-UHFFFAOYSA-N 0.000 description 1
• FZDHYMSKZUAVGQ-UHFFFAOYSA-N 4-bromo-5-[4-[[3-(trifluoromethoxy)phenyl]methyl]piperazin-1-yl]-1-benzofuran-2-carboxamide Chemical compound C=1C=C2OC(C(=O)N)=CC2=C(Br)C=1N(CC1)CCN1CC1=CC=CC(OC(F)(F)F)=C1 FZDHYMSKZUAVGQ-UHFFFAOYSA-N 0.000 description 1
• JPNIXLYMBMEYQF-UHFFFAOYSA-N 4-bromo-5-[4-[[3-(trifluoromethoxy)phenyl]methyl]piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Br)C=1N(CC1)CCN1CC1=CC=CC(OC(F)(F)F)=C1 JPNIXLYMBMEYQF-UHFFFAOYSA-N 0.000 description 1
• RTXRYFJUNJBQCM-UHFFFAOYSA-N 4-bromo-5-[4-[[3-(trifluoromethyl)phenyl]methoxy]piperidin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Br)C=1N(CC1)CCC1OCC1=CC=CC(C(F)(F)F)=C1 RTXRYFJUNJBQCM-UHFFFAOYSA-N 0.000 description 1
• OFEBLJJKYKQYOH-UHFFFAOYSA-N 4-bromo-5-[4-[[3-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]-1-benzofuran-2-carboxamide Chemical compound C=1C=C2OC(C(=O)N)=CC2=C(Br)C=1N(CC1)CCN1CC1=CC=CC(C(F)(F)F)=C1 OFEBLJJKYKQYOH-UHFFFAOYSA-N 0.000 description 1
• PKRQKRQVASHJRC-UHFFFAOYSA-N 4-bromo-5-[4-[[3-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Br)C=1N(CC1)CCN1CC1=CC=CC(C(F)(F)F)=C1 PKRQKRQVASHJRC-UHFFFAOYSA-N 0.000 description 1
• QYKZDVHGRAFAMV-UHFFFAOYSA-N 4-bromo-5-[[1-(2,3-dichlorobenzoyl)piperidin-4-yl]amino]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Br)C=1NC(CC1)CCN1C(=O)C1=CC=CC(Cl)=C1Cl QYKZDVHGRAFAMV-UHFFFAOYSA-N 0.000 description 1
• ANJBFEYWDSNDON-UHFFFAOYSA-N 4-bromo-5-[[1-(2,6-dichlorobenzoyl)piperidin-4-yl]amino]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Br)C=1NC(CC1)CCN1C(=O)C1=C(Cl)C=CC=C1Cl ANJBFEYWDSNDON-UHFFFAOYSA-N 0.000 description 1
• LSKWHWXETAGHKF-UHFFFAOYSA-N 4-bromo-n-ethoxy-5-[4-(3-fluorophenyl)sulfonylpiperazin-1-yl]-1-benzofuran-2-carboxamide Chemical compound C=1C=C2OC(C(=O)NOCC)=CC2=C(Br)C=1N(CC1)CCN1S(=O)(=O)C1=CC=CC(F)=C1 LSKWHWXETAGHKF-UHFFFAOYSA-N 0.000 description 1
• 125000004800 4-bromophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Br 0.000 description 1
• SQPRXGITMCKRDM-UHFFFAOYSA-N 4-chloro-5-[4-(2,3-dichlorophenyl)sulfonyl-1,4-diazepan-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Cl)C=1N(CC1)CCCN1S(=O)(=O)C1=CC=CC(Cl)=C1Cl SQPRXGITMCKRDM-UHFFFAOYSA-N 0.000 description 1
• QPLITVXTFDDNSF-UHFFFAOYSA-N 4-chloro-5-[4-(2,3-dichlorophenyl)sulfonylpiperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Cl)C=1N(CC1)CCN1S(=O)(=O)C1=CC=CC(Cl)=C1Cl QPLITVXTFDDNSF-UHFFFAOYSA-N 0.000 description 1
• UQIXEWZJPXUSIK-UHFFFAOYSA-N 4-chloro-5-[4-(2,3-dihydroindol-1-yl)piperidin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C1CC2=CC=CC=C2N1C(CC1)CCN1C1=CC=C(OC(C(=O)O)=C2)C2=C1Cl UQIXEWZJPXUSIK-UHFFFAOYSA-N 0.000 description 1
• KAIGJXSGODBUCH-UHFFFAOYSA-N 4-chloro-5-[4-(2,5-dichlorobenzoyl)piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Cl)C=1N(CC1)CCN1C(=O)C1=CC(Cl)=CC=C1Cl KAIGJXSGODBUCH-UHFFFAOYSA-N 0.000 description 1
• HNMBBJUDGSUSTF-UHFFFAOYSA-N 4-chloro-5-[4-(2,5-dichlorophenyl)sulfonyl-1,4-diazepan-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Cl)C=1N(CC1)CCCN1S(=O)(=O)C1=CC(Cl)=CC=C1Cl HNMBBJUDGSUSTF-UHFFFAOYSA-N 0.000 description 1
• GAWJMFQHOKFRMK-UHFFFAOYSA-N 4-chloro-5-[4-(2,5-dichlorophenyl)sulfonylpiperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Cl)C=1N(CC1)CCN1S(=O)(=O)C1=CC(Cl)=CC=C1Cl GAWJMFQHOKFRMK-UHFFFAOYSA-N 0.000 description 1
• NSAIRUSQURRYPG-UHFFFAOYSA-N 4-chloro-5-[4-(2,6-dichlorobenzoyl)piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Cl)C=1N(CC1)CCN1C(=O)C1=C(Cl)C=CC=C1Cl NSAIRUSQURRYPG-UHFFFAOYSA-N 0.000 description 1
• SADOMPOHZDUJID-UHFFFAOYSA-N 4-chloro-5-[4-(2,6-dichlorophenyl)sulfonyl-1,4-diazepan-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Cl)C=1N(CC1)CCCN1S(=O)(=O)C1=C(Cl)C=CC=C1Cl SADOMPOHZDUJID-UHFFFAOYSA-N 0.000 description 1
• QIIMKWJVMPLIBR-UHFFFAOYSA-N 4-chloro-5-[4-(2-chlorophenyl)sulfonyl-1,4-diazepan-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Cl)C=1N(CC1)CCCN1S(=O)(=O)C1=CC=CC=C1Cl QIIMKWJVMPLIBR-UHFFFAOYSA-N 0.000 description 1
• SZPCMFHAGMFEDP-UHFFFAOYSA-N 4-chloro-5-[4-(2-chlorophenyl)sulfonylpiperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Cl)C=1N(CC1)CCN1S(=O)(=O)C1=CC=CC=C1Cl SZPCMFHAGMFEDP-UHFFFAOYSA-N 0.000 description 1
• YLWYUGFINAALAC-UHFFFAOYSA-N 4-chloro-5-[4-(3,5-dichlorobenzoyl)piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Cl)C=1N(CC1)CCN1C(=O)C1=CC(Cl)=CC(Cl)=C1 YLWYUGFINAALAC-UHFFFAOYSA-N 0.000 description 1
• UTORGWRRQJXALC-UHFFFAOYSA-N 4-chloro-5-[4-(3-chlorobenzoyl)piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Cl)C=1N(CC1)CCN1C(=O)C1=CC=CC(Cl)=C1 UTORGWRRQJXALC-UHFFFAOYSA-N 0.000 description 1
• RHKLGCATOMREAN-UHFFFAOYSA-N 4-chloro-5-[4-(3-chlorophenyl)sulfonylpiperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Cl)C=1N(CC1)CCN1S(=O)(=O)C1=CC=CC(Cl)=C1 RHKLGCATOMREAN-UHFFFAOYSA-N 0.000 description 1
• GCYMFJNRDDWRON-UHFFFAOYSA-N 4-chloro-5-[4-(3-cyanophenyl)sulfonylpiperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Cl)C=1N(CC1)CCN1S(=O)(=O)C1=CC=CC(C#N)=C1 GCYMFJNRDDWRON-UHFFFAOYSA-N 0.000 description 1
• DDLNCMLMFLTZPQ-UHFFFAOYSA-N 4-chloro-5-[4-(3-fluorobenzoyl)piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Cl)C=1N(CC1)CCN1C(=O)C1=CC=CC(F)=C1 DDLNCMLMFLTZPQ-UHFFFAOYSA-N 0.000 description 1
• GBDORWUJJBUCIG-UHFFFAOYSA-N 4-chloro-5-[4-(3-fluorophenyl)sulfonylpiperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Cl)C=1N(CC1)CCN1S(=O)(=O)C1=CC=CC(F)=C1 GBDORWUJJBUCIG-UHFFFAOYSA-N 0.000 description 1
• SORPMCGPFQWPAB-UHFFFAOYSA-N 4-chloro-5-[4-(3-methoxybenzoyl)piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound COC1=CC=CC(C(=O)N2CCN(CC2)C=2C(=C3C=C(OC3=CC=2)C(O)=O)Cl)=C1 SORPMCGPFQWPAB-UHFFFAOYSA-N 0.000 description 1
• ZDYGYWRZNIYJPE-UHFFFAOYSA-N 4-chloro-5-[4-(3-methoxyphenyl)sulfonylpiperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound COC1=CC=CC(S(=O)(=O)N2CCN(CC2)C=2C(=C3C=C(OC3=CC=2)C(O)=O)Cl)=C1 ZDYGYWRZNIYJPE-UHFFFAOYSA-N 0.000 description 1
• WJJJCRDSVRLPGR-UHFFFAOYSA-N 4-chloro-5-[4-(4-chlorophenyl)sulfonylpiperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Cl)C=1N(CC1)CCN1S(=O)(=O)C1=CC=C(Cl)C=C1 WJJJCRDSVRLPGR-UHFFFAOYSA-N 0.000 description 1
• NTDFBFFVIFXUAA-UHFFFAOYSA-N 4-chloro-5-[4-(4-methoxyphenyl)sulfonylpiperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C1=CC(OC)=CC=C1S(=O)(=O)N1CCN(C=2C(=C3C=C(OC3=CC=2)C(O)=O)Cl)CC1 NTDFBFFVIFXUAA-UHFFFAOYSA-N 0.000 description 1
• AQDVEZZRFUCVBO-UHFFFAOYSA-N 4-chloro-5-[4-(pyridin-3-ylmethyl)piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Cl)C=1N(CC1)CCN1CC1=CC=CN=C1 AQDVEZZRFUCVBO-UHFFFAOYSA-N 0.000 description 1
• YNXJWTWDJCIIPW-UHFFFAOYSA-N 4-chloro-5-[4-[(2,5-dichlorophenyl)methyl]piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Cl)C=1N(CC1)CCN1CC1=CC(Cl)=CC=C1Cl YNXJWTWDJCIIPW-UHFFFAOYSA-N 0.000 description 1
• CKJDIYNUVUIYKF-UHFFFAOYSA-N 4-chloro-5-[4-[(2-chloro-6-fluorophenyl)methyl]piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Cl)C=1N(CC1)CCN1CC1=C(F)C=CC=C1Cl CKJDIYNUVUIYKF-UHFFFAOYSA-N 0.000 description 1
• MRSNOANUMVMCMP-UHFFFAOYSA-N 4-chloro-5-[4-[(2-chloro-6-hydroxyphenyl)methyl]piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Cl)C=1N(CC1)CCN1CC1=C(O)C=CC=C1Cl MRSNOANUMVMCMP-UHFFFAOYSA-N 0.000 description 1
• XSXTVPYJFJLESZ-UHFFFAOYSA-N 4-chloro-5-[4-[(2-chloro-6-methoxyphenyl)methyl]piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound COC1=CC=CC(Cl)=C1CN1CCN(C=2C(=C3C=C(OC3=CC=2)C(O)=O)Cl)CC1 XSXTVPYJFJLESZ-UHFFFAOYSA-N 0.000 description 1
• UKIYREZXHAMXJV-UHFFFAOYSA-N 4-chloro-5-[4-[(2-chlorophenyl)methyl]piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Cl)C=1N(CC1)CCN1CC1=CC=CC=C1Cl UKIYREZXHAMXJV-UHFFFAOYSA-N 0.000 description 1
• XFRNOIILXPFRPY-UHFFFAOYSA-N 4-chloro-5-[4-[(2-fluorophenyl)methyl]piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Cl)C=1N(CC1)CCN1CC1=CC=CC=C1F XFRNOIILXPFRPY-UHFFFAOYSA-N 0.000 description 1
• KQZQCHRTTQEGQE-UHFFFAOYSA-N 4-chloro-5-[4-[(2-methyl-5-thiophen-2-ylpyrazol-3-yl)methyl]piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C1=C(CN2CCN(CC2)C=2C(=C3C=C(OC3=CC=2)C(O)=O)Cl)N(C)N=C1C1=CC=CS1 KQZQCHRTTQEGQE-UHFFFAOYSA-N 0.000 description 1
• KFSHPJPQTDIRCR-UHFFFAOYSA-N 4-chloro-5-[4-[(2-methylpropan-2-yl)oxycarbonyl]-1,4-diazepan-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C1CN(C(=O)OC(C)(C)C)CCCN1C1=CC=C(OC(=C2)C(O)=O)C2=C1Cl KFSHPJPQTDIRCR-UHFFFAOYSA-N 0.000 description 1
• AKNDNVXMZOSJPO-UHFFFAOYSA-N 4-chloro-5-[4-[(2-methylpropan-2-yl)oxycarbonyl]piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1C1=CC=C(OC(=C2)C(O)=O)C2=C1Cl AKNDNVXMZOSJPO-UHFFFAOYSA-N 0.000 description 1
• NXQYKTFDILOXTH-UHFFFAOYSA-N 4-chloro-5-[4-[(3,5-dichlorophenyl)methyl]piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Cl)C=1N(CC1)CCN1CC1=CC(Cl)=CC(Cl)=C1 NXQYKTFDILOXTH-UHFFFAOYSA-N 0.000 description 1
• PNQXANUEDSHZSU-UHFFFAOYSA-N 4-chloro-5-[4-[(3,5-dimethoxyphenyl)methyl]piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound COC1=CC(OC)=CC(CN2CCN(CC2)C=2C(=C3C=C(OC3=CC=2)C(O)=O)Cl)=C1 PNQXANUEDSHZSU-UHFFFAOYSA-N 0.000 description 1
• UNUHAADAJRFJSU-UHFFFAOYSA-N 4-chloro-5-[4-[(3-chlorophenyl)methyl]piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Cl)C=1N(CC1)CCN1CC1=CC=CC(Cl)=C1 UNUHAADAJRFJSU-UHFFFAOYSA-N 0.000 description 1
• VQLBKNZTUHDSCC-UHFFFAOYSA-N 4-chloro-5-[4-[(3-chlorophenyl)methylsulfonyl]piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Cl)C=1N(CC1)CCN1S(=O)(=O)CC1=CC=CC(Cl)=C1 VQLBKNZTUHDSCC-UHFFFAOYSA-N 0.000 description 1
• NTSAZWYUOSGYNM-UHFFFAOYSA-N 4-chloro-5-[4-[(3-ethoxy-2-hydroxyphenyl)methyl]piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound CCOC1=CC=CC(CN2CCN(CC2)C=2C(=C3C=C(OC3=CC=2)C(O)=O)Cl)=C1O NTSAZWYUOSGYNM-UHFFFAOYSA-N 0.000 description 1
• ONOJEIGDDVHBHY-UHFFFAOYSA-N 4-chloro-5-[4-[(3-fluorophenyl)methyl]piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Cl)C=1N(CC1)CCN1CC1=CC=CC(F)=C1 ONOJEIGDDVHBHY-UHFFFAOYSA-N 0.000 description 1
• BWGAAVJRHVGRFP-UHFFFAOYSA-N 4-chloro-5-[4-[(4-chlorophenyl)methyl]piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Cl)C=1N(CC1)CCN1CC1=CC=C(Cl)C=C1 BWGAAVJRHVGRFP-UHFFFAOYSA-N 0.000 description 1
• WFBGMVNYLZDIMQ-UHFFFAOYSA-N 4-chloro-5-[4-[(4-fluorophenyl)methyl]piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Cl)C=1N(CC1)CCN1CC1=CC=C(F)C=C1 WFBGMVNYLZDIMQ-UHFFFAOYSA-N 0.000 description 1
• JBLLLRWVPJSKJX-UHFFFAOYSA-N 4-chloro-5-[4-[3-(trifluoromethoxy)benzoyl]piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Cl)C=1N(CC1)CCN1C(=O)C1=CC=CC(OC(F)(F)F)=C1 JBLLLRWVPJSKJX-UHFFFAOYSA-N 0.000 description 1
• QSKMMVCCCDXRKJ-UHFFFAOYSA-N 4-chloro-5-[4-[3-(trifluoromethyl)benzoyl]piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Cl)C=1N(CC1)CCN1C(=O)C1=CC=CC(C(F)(F)F)=C1 QSKMMVCCCDXRKJ-UHFFFAOYSA-N 0.000 description 1
• IPFMLEARHADFOW-UHFFFAOYSA-N 4-chloro-5-[4-[5-(trifluoromethyl)pyridin-2-yl]oxypiperidin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Cl)C=1N(CC1)CCC1OC1=CC=C(C(F)(F)F)C=N1 IPFMLEARHADFOW-UHFFFAOYSA-N 0.000 description 1
• NGADRNRKOFWZMJ-UHFFFAOYSA-N 4-chloro-5-[4-[[2-chloro-3-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Cl)C=1N(CC1)CCN1CC1=CC=CC(C(F)(F)F)=C1Cl NGADRNRKOFWZMJ-UHFFFAOYSA-N 0.000 description 1
• RNVLASUWDQPGOE-UHFFFAOYSA-N 4-chloro-5-[4-[[3-(trifluoromethoxy)phenyl]methyl]piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Cl)C=1N(CC1)CCN1CC1=CC=CC(OC(F)(F)F)=C1 RNVLASUWDQPGOE-UHFFFAOYSA-N 0.000 description 1
• ZKBMZZWPQJEOPM-UHFFFAOYSA-N 4-chloro-5-[4-[[3-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Cl)C=1N(CC1)CCN1CC1=CC=CC(C(F)(F)F)=C1 ZKBMZZWPQJEOPM-UHFFFAOYSA-N 0.000 description 1
• HBRWLPPRMCDRIZ-UHFFFAOYSA-N 4-chloro-5-[[1-(2,6-dichlorophenyl)sulfonylpiperidin-4-yl]amino]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Cl)C=1NC(CC1)CCN1S(=O)(=O)C1=C(Cl)C=CC=C1Cl HBRWLPPRMCDRIZ-UHFFFAOYSA-N 0.000 description 1
• RGAMARDGXPDVNE-UHFFFAOYSA-N 4-chloro-5-[[1-(3-chlorophenyl)sulfonylpiperidin-4-yl]amino]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Cl)C=1NC(CC1)CCN1S(=O)(=O)C1=CC=CC(Cl)=C1 RGAMARDGXPDVNE-UHFFFAOYSA-N 0.000 description 1
• YCTDUBMXOFFTSC-UHFFFAOYSA-N 4-cyano-5-[4-[(2-methylpropan-2-yl)oxycarbonyl]piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1C1=CC=C(OC(=C2)C(O)=O)C2=C1C#N YCTDUBMXOFFTSC-UHFFFAOYSA-N 0.000 description 1
• 125000004860 4-ethylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])C([H])([H])[H] 0.000 description 1
• MMKRPRBZLJZRBL-UHFFFAOYSA-N 4-methyl-5-[4-(2-methyl-1h-benzimidazole-4-carbonyl)piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C1=C2OC(C(O)=O)=CC2=C(C)C(N2CCN(CC2)C(=O)C2=C3N=C(NC3=CC=C2)C)=C1 MMKRPRBZLJZRBL-UHFFFAOYSA-N 0.000 description 1
• FRRUHLISZXTOPL-UHFFFAOYSA-N 4-methyl-5-[4-(naphthalen-1-ylmethyl)piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C1=CC=C2C(CN3CCN(CC3)C3=C(C=4C=C(OC=4C=C3)C(O)=O)C)=CC=CC2=C1 FRRUHLISZXTOPL-UHFFFAOYSA-N 0.000 description 1
• CSOBWBUFCRGSOW-UHFFFAOYSA-N 4-methyl-5-[4-[(2,3,6-trichlorophenyl)methyl]piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C1=CC=2OC(C(O)=O)=CC=2C(C)=C1N(CC1)CCN1CC1=C(Cl)C=CC(Cl)=C1Cl CSOBWBUFCRGSOW-UHFFFAOYSA-N 0.000 description 1
• HWGDHHVPMAAGAK-UHFFFAOYSA-N 4-methyl-5-[4-[(2-methylpropan-2-yl)oxycarbonyl]piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C1=CC=2OC(C(O)=O)=CC=2C(C)=C1N1CCN(C(=O)OC(C)(C)C)CC1 HWGDHHVPMAAGAK-UHFFFAOYSA-N 0.000 description 1
• AMXJLAKXMSANTO-UHFFFAOYSA-N 4-methyl-5-[4-[3-(trifluoromethoxy)benzoyl]piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C1=CC=2OC(C(O)=O)=CC=2C(C)=C1N(CC1)CCN1C(=O)C1=CC=CC(OC(F)(F)F)=C1 AMXJLAKXMSANTO-UHFFFAOYSA-N 0.000 description 1
• BUMKMAHEBSFUJJ-UHFFFAOYSA-N 4-methyl-5-[4-[3-(trifluoromethyl)benzoyl]piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C1=CC=2OC(C(O)=O)=CC=2C(C)=C1N(CC1)CCN1C(=O)C1=CC=CC(C(F)(F)F)=C1 BUMKMAHEBSFUJJ-UHFFFAOYSA-N 0.000 description 1
• HKPVSXHWKFEMKP-UHFFFAOYSA-N 4-methyl-5-[4-[5-(trifluoromethyl)pyridin-2-yl]oxypiperidin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C1=CC=2OC(C(O)=O)=CC=2C(C)=C1N(CC1)CCC1OC1=CC=C(C(F)(F)F)C=N1 HKPVSXHWKFEMKP-UHFFFAOYSA-N 0.000 description 1
• GDAWSSSSTVHSKI-UHFFFAOYSA-N 4-methyl-5-[4-[[3-(trifluoromethoxy)phenyl]methyl]piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C1=CC=2OC(C(O)=O)=CC=2C(C)=C1N(CC1)CCN1CC1=CC=CC(OC(F)(F)F)=C1 GDAWSSSSTVHSKI-UHFFFAOYSA-N 0.000 description 1
• CFRLVOLZZHODIT-UHFFFAOYSA-N 4-methyl-5-[4-[[3-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C1=CC=2OC(C(O)=O)=CC=2C(C)=C1N(CC1)CCN1CC1=CC=CC(C(F)(F)F)=C1 CFRLVOLZZHODIT-UHFFFAOYSA-N 0.000 description 1
• JLVOOJVOZFELQA-UHFFFAOYSA-N 5-(4-benzhydrylpiperazin-1-yl)-4-methyl-1-benzofuran-2-carboxylic acid Chemical compound C1=CC=2OC(C(O)=O)=CC=2C(C)=C1N(CC1)CCN1C(C=1C=CC=CC=1)C1=CC=CC=C1 JLVOOJVOZFELQA-UHFFFAOYSA-N 0.000 description 1
• KTBOHRAZOMGZFN-UHFFFAOYSA-N 5-(4-benzoylpiperazin-1-yl)-4-bromo-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Br)C=1N(CC1)CCN1C(=O)C1=CC=CC=C1 KTBOHRAZOMGZFN-UHFFFAOYSA-N 0.000 description 1
• PQPCPASQRLDAKY-UHFFFAOYSA-N 5-(4-benzylpiperazin-1-yl)-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=CC=1N(CC1)CCN1CC1=CC=CC=C1 PQPCPASQRLDAKY-UHFFFAOYSA-N 0.000 description 1
• WIPJMZDAHAGGLW-UHFFFAOYSA-N 5-[2-[2-chloro-4-[[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]methoxy]phenyl]cyclopropyl]pyridine-2-carboxylic acid Chemical compound C1=NC(C(=O)O)=CC=C1C1C(C=2C(=CC(OCC3=C(ON=C3C=3C(=CC=CC=3Cl)Cl)C3CC3)=CC=2)Cl)C1 WIPJMZDAHAGGLW-UHFFFAOYSA-N 0.000 description 1
• RECGOOIVMAFZGM-UHFFFAOYSA-N 5-[3-[2-chloro-4-[[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]methoxy]phenyl]-3-hydroxyazetidin-1-yl]pyridine-3-carboxylic acid Chemical compound OC(=O)C1=CN=CC(N2CC(O)(C2)C=2C(=CC(OCC=3C(=NOC=3C3CC3)C=3C(=CC=CC=3Cl)Cl)=CC=2)Cl)=C1 RECGOOIVMAFZGM-UHFFFAOYSA-N 0.000 description 1
• KHTWMUPBBFFKQN-UHFFFAOYSA-N 5-[3-[2-chloro-4-[[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]methoxy]phenyl]-3-hydroxycyclobutyl]-1-propan-2-ylpyrazole-3-carboxylic acid Chemical compound CC(C)N1N=C(C(O)=O)C=C1C1CC(O)(C=2C(=CC(OCC=3C(=NOC=3C3CC3)C=3C(=CC=CC=3Cl)Cl)=CC=2)Cl)C1 KHTWMUPBBFFKQN-UHFFFAOYSA-N 0.000 description 1
• OKXJAWZTSLKZBI-UHFFFAOYSA-N 5-[4-(1,3-benzodioxol-4-ylmethyl)piperazin-1-yl]-4-bromo-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Br)C=1N(CC1)CCN1CC1=CC=CC2=C1OCO2 OKXJAWZTSLKZBI-UHFFFAOYSA-N 0.000 description 1
• MDBBWCQQQDXAFU-UHFFFAOYSA-N 5-[4-(2,3-dichlorophenyl)sulfonylpiperazin-1-yl]-4-methyl-1-benzofuran-2-carboxylic acid Chemical compound C1=CC=2OC(C(O)=O)=CC=2C(C)=C1N(CC1)CCN1S(=O)(=O)C1=CC=CC(Cl)=C1Cl MDBBWCQQQDXAFU-UHFFFAOYSA-N 0.000 description 1
• WZZBUKRZZXLUHH-UHFFFAOYSA-N 5-[4-(2,5-dichlorobenzoyl)piperazin-1-yl]-4-methyl-1-benzofuran-2-carboxylic acid Chemical compound C1=CC=2OC(C(O)=O)=CC=2C(C)=C1N(CC1)CCN1C(=O)C1=CC(Cl)=CC=C1Cl WZZBUKRZZXLUHH-UHFFFAOYSA-N 0.000 description 1
• HARQHABCUCWJFM-UHFFFAOYSA-N 5-[4-(2,5-dichlorophenyl)sulfonyl-1,4-diazepan-1-yl]-4-methyl-1-benzofuran-2-carboxylic acid Chemical compound C1=CC=2OC(C(O)=O)=CC=2C(C)=C1N(CC1)CCCN1S(=O)(=O)C1=CC(Cl)=CC=C1Cl HARQHABCUCWJFM-UHFFFAOYSA-N 0.000 description 1
• IFMBIWNBHHQBMW-UHFFFAOYSA-N 5-[4-(2,5-dichlorophenyl)sulfonylpiperazin-1-yl]-4-methyl-1-benzofuran-2-carboxylic acid Chemical compound C1=CC=2OC(C(O)=O)=CC=2C(C)=C1N(CC1)CCN1S(=O)(=O)C1=CC(Cl)=CC=C1Cl IFMBIWNBHHQBMW-UHFFFAOYSA-N 0.000 description 1
• ALEMAFZREQJXLP-UHFFFAOYSA-N 5-[4-(2,6-dichlorophenyl)sulfonylpiperazin-1-yl]-4-methyl-1-benzofuran-2-carboxylic acid Chemical compound C1=CC=2OC(C(O)=O)=CC=2C(C)=C1N(CC1)CCN1S(=O)(=O)C1=C(Cl)C=CC=C1Cl ALEMAFZREQJXLP-UHFFFAOYSA-N 0.000 description 1
• TXGMHGOCDTWTBN-UHFFFAOYSA-N 5-[4-(2-chlorophenyl)sulfonylpiperazin-1-yl]-4-methyl-1-benzofuran-2-carboxylic acid Chemical compound C1=CC=2OC(C(O)=O)=CC=2C(C)=C1N(CC1)CCN1S(=O)(=O)C1=CC=CC=C1Cl TXGMHGOCDTWTBN-UHFFFAOYSA-N 0.000 description 1
• KPOPRXXXGMTSAL-UHFFFAOYSA-N 5-[4-(2-fluorophenyl)sulfonylpiperazin-1-yl]-4-methyl-1-benzofuran-2-carboxylic acid Chemical compound C1=CC=2OC(C(O)=O)=CC=2C(C)=C1N(CC1)CCN1S(=O)(=O)C1=CC=CC=C1F KPOPRXXXGMTSAL-UHFFFAOYSA-N 0.000 description 1
• MBYSPTRMAUOAGX-UHFFFAOYSA-N 5-[4-(3-chlorophenyl)sulfonylpiperazin-1-yl]-4-methyl-1-benzofuran-2-carboxylic acid Chemical compound C1=CC=2OC(C(O)=O)=CC=2C(C)=C1N(CC1)CCN1S(=O)(=O)C1=CC=CC(Cl)=C1 MBYSPTRMAUOAGX-UHFFFAOYSA-N 0.000 description 1
• PBYKJSBNLFVASH-UHFFFAOYSA-N 5-[4-(3-fluorobenzoyl)piperazin-1-yl]-1-benzofuran-2-carboxamide Chemical compound C=1C=C2OC(C(=O)N)=CC2=CC=1N(CC1)CCN1C(=O)C1=CC=CC(F)=C1 PBYKJSBNLFVASH-UHFFFAOYSA-N 0.000 description 1
• ICQLFFUZDUQVOY-UHFFFAOYSA-N 5-[4-(3-fluorophenyl)sulfonylpiperazin-1-yl]-4-methyl-1-benzofuran-2-carboxylic acid Chemical compound C1=CC=2OC(C(O)=O)=CC=2C(C)=C1N(CC1)CCN1S(=O)(=O)C1=CC=CC(F)=C1 ICQLFFUZDUQVOY-UHFFFAOYSA-N 0.000 description 1
• ZAHCUSJPEVWYHO-UHFFFAOYSA-N 5-[4-(3-methoxyphenyl)sulfonylpiperazin-1-yl]-1-benzofuran-2-carboxamide Chemical compound COC1=CC=CC(S(=O)(=O)N2CCN(CC2)C=2C=C3C=C(OC3=CC=2)C(N)=O)=C1 ZAHCUSJPEVWYHO-UHFFFAOYSA-N 0.000 description 1
• HSFDGOALMMNZBC-UHFFFAOYSA-N 5-[4-(3-methoxyphenyl)sulfonylpiperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound COC1=CC=CC(S(=O)(=O)N2CCN(CC2)C=2C=C3C=C(OC3=CC=2)C(O)=O)=C1 HSFDGOALMMNZBC-UHFFFAOYSA-N 0.000 description 1
• GJWRCTHMRBFMIP-UHFFFAOYSA-N 5-[4-(3h-benzimidazole-5-carbonyl)piperazin-1-yl]-4-bromo-1-benzofuran-2-carboxylic acid Chemical compound C1=C2NC=NC2=CC(C(=O)N2CCN(CC2)C=2C(Br)=C3C=C(OC3=CC=2)C(=O)O)=C1 GJWRCTHMRBFMIP-UHFFFAOYSA-N 0.000 description 1
• XAJNDQZTMKMSSQ-UHFFFAOYSA-N 5-[4-(3h-benzimidazole-5-carbonyl)piperazin-1-yl]-4-chloro-1-benzofuran-2-carboxylic acid Chemical compound C1=C2NC=NC2=CC(C(=O)N2CCN(CC2)C=2C(Cl)=C3C=C(OC3=CC=2)C(=O)O)=C1 XAJNDQZTMKMSSQ-UHFFFAOYSA-N 0.000 description 1
• OKTJXUGSIOWUTE-UHFFFAOYSA-N 5-[4-(4-methoxyphenyl)sulfonylpiperazin-1-yl]-1-benzofuran-2-carboxamide Chemical compound C1=CC(OC)=CC=C1S(=O)(=O)N1CCN(C=2C=C3C=C(OC3=CC=2)C(N)=O)CC1 OKTJXUGSIOWUTE-UHFFFAOYSA-N 0.000 description 1
• RNOJZARMPMPGIC-UHFFFAOYSA-N 5-[4-(adamantane-1-carbonyl)piperazin-1-yl]-4-bromo-1-benzofuran-2-carboxylic acid Chemical compound C1C(C2)CC(C3)CC2CC13C(=O)N(CC1)CCN1C1=CC=C(OC(C(=O)O)=C2)C2=C1Br RNOJZARMPMPGIC-UHFFFAOYSA-N 0.000 description 1
• WFEWQSRNHPTQPN-UHFFFAOYSA-N 5-[4-(benzenesulfonyl)piperazin-1-yl]-4-bromo-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Br)C=1N(CC1)CCN1S(=O)(=O)C1=CC=CC=C1 WFEWQSRNHPTQPN-UHFFFAOYSA-N 0.000 description 1
• HGRYHODWWMHHSZ-UHFFFAOYSA-N 5-[4-[(2,3-dichlorophenyl)methyl]piperazin-1-yl]-4-methyl-1-benzofuran-2-carboxylic acid Chemical compound C1=CC=2OC(C(O)=O)=CC=2C(C)=C1N(CC1)CCN1CC1=CC=CC(Cl)=C1Cl HGRYHODWWMHHSZ-UHFFFAOYSA-N 0.000 description 1
• RFWBMYXFQAEJHB-UHFFFAOYSA-N 5-[4-[(2,3-dimethoxyphenyl)methyl]piperazin-1-yl]-4-methyl-1-benzofuran-2-carboxylic acid Chemical compound COC1=CC=CC(CN2CCN(CC2)C=2C(=C3C=C(OC3=CC=2)C(O)=O)C)=C1OC RFWBMYXFQAEJHB-UHFFFAOYSA-N 0.000 description 1
• UZALFXGUFFDMGL-UHFFFAOYSA-N 5-[4-[(2,4-dichlorophenyl)carbamoyl]piperidin-1-yl]-4-methyl-1-benzofuran-2-carboxylic acid Chemical compound C1=CC=2OC(C(O)=O)=CC=2C(C)=C1N(CC1)CCC1C(=O)NC1=CC=C(Cl)C=C1Cl UZALFXGUFFDMGL-UHFFFAOYSA-N 0.000 description 1
• IMSZKLCYSWAQPG-UHFFFAOYSA-N 5-[4-[(2,5-dichlorophenyl)methyl]piperazin-1-yl]-4-methyl-1-benzofuran-2-carboxylic acid Chemical compound C1=CC=2OC(C(O)=O)=CC=2C(C)=C1N(CC1)CCN1CC1=CC(Cl)=CC=C1Cl IMSZKLCYSWAQPG-UHFFFAOYSA-N 0.000 description 1
• HZLSTYFGILYBLR-UHFFFAOYSA-N 5-[4-[(2,6-dichlorophenyl)methyl]-1,4-diazepan-1-yl]-4-methyl-1-benzofuran-2-carboxylic acid Chemical compound C1=CC=2OC(C(O)=O)=CC=2C(C)=C1N(CC1)CCCN1CC1=C(Cl)C=CC=C1Cl HZLSTYFGILYBLR-UHFFFAOYSA-N 0.000 description 1
• HYPYFUPEKWUDOW-UHFFFAOYSA-N 5-[4-[(2,6-dichlorophenyl)methyl]piperazin-1-yl]-4-methyl-1-benzofuran-2-carboxamide Chemical compound C1=CC=2OC(C(N)=O)=CC=2C(C)=C1N(CC1)CCN1CC1=C(Cl)C=CC=C1Cl HYPYFUPEKWUDOW-UHFFFAOYSA-N 0.000 description 1
• VTVAUPGKXXUSPK-UHFFFAOYSA-N 5-[4-[(2,6-dichlorophenyl)methyl]piperazin-1-yl]-4-methyl-1-benzofuran-2-carboxylic acid Chemical compound C1=CC=2OC(C(O)=O)=CC=2C(C)=C1N(CC1)CCN1CC1=C(Cl)C=CC=C1Cl VTVAUPGKXXUSPK-UHFFFAOYSA-N 0.000 description 1
• RXONGIHORQKIKZ-UHFFFAOYSA-N 5-[4-[(2-chloro-6-fluorophenyl)methyl]piperazin-1-yl]-4-methyl-1-benzofuran-2-carboxylic acid Chemical compound C1=CC=2OC(C(O)=O)=CC=2C(C)=C1N(CC1)CCN1CC1=C(F)C=CC=C1Cl RXONGIHORQKIKZ-UHFFFAOYSA-N 0.000 description 1
• XAIYPZOYWVTYAJ-UHFFFAOYSA-N 5-[4-[(2-chlorophenyl)methyl]piperazin-1-yl]-4-methyl-1-benzofuran-2-carboxylic acid Chemical compound C1=CC=2OC(C(O)=O)=CC=2C(C)=C1N(CC1)CCN1CC1=CC=CC=C1Cl XAIYPZOYWVTYAJ-UHFFFAOYSA-N 0.000 description 1
• MKMSFJZGYKVTBY-UHFFFAOYSA-N 5-[4-[(2-fluorophenyl)methyl]piperazin-1-yl]-4-methyl-1-benzofuran-2-carboxylic acid Chemical compound C1=CC=2OC(C(O)=O)=CC=2C(C)=C1N(CC1)CCN1CC1=CC=CC=C1F MKMSFJZGYKVTBY-UHFFFAOYSA-N 0.000 description 1
• KKVOQHMDIMYCHQ-UHFFFAOYSA-N 5-[4-[(2-methylpropan-2-yl)oxycarbonyl]piperazin-1-yl]-1-benzofuran-2-carboxylic acid Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1C1=CC=C(OC(=C2)C(O)=O)C2=C1 KKVOQHMDIMYCHQ-UHFFFAOYSA-N 0.000 description 1
• HQDNIKCGBAAQLJ-UHFFFAOYSA-N 5-[4-[(3,5-dichloro-2-hydroxyphenyl)methyl]piperazin-1-yl]-4-methyl-1-benzofuran-2-carboxylic acid Chemical compound C1=CC=2OC(C(O)=O)=CC=2C(C)=C1N(CC1)CCN1CC1=CC(Cl)=CC(Cl)=C1O HQDNIKCGBAAQLJ-UHFFFAOYSA-N 0.000 description 1
• ISXISOJECZBORY-UHFFFAOYSA-N 5-[4-[(3,5-dichlorophenyl)methyl]piperazin-1-yl]-4-methyl-1-benzofuran-2-carboxylic acid Chemical compound C1=CC=2OC(C(O)=O)=CC=2C(C)=C1N(CC1)CCN1CC1=CC(Cl)=CC(Cl)=C1 ISXISOJECZBORY-UHFFFAOYSA-N 0.000 description 1
• UZNZPKWELRIODT-UHFFFAOYSA-N 5-[4-[(3-carboxyphenyl)methyl]piperazin-1-yl]-4-chloro-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Cl)C=1N(CC1)CCN1CC1=CC=CC(C(O)=O)=C1 UZNZPKWELRIODT-UHFFFAOYSA-N 0.000 description 1
• UVKBMQYZNVXBGB-UHFFFAOYSA-N 5-[4-[(3-chlorophenyl)methyl]piperazin-1-yl]-1-benzofuran-2-carboxamide Chemical compound C=1C=C2OC(C(=O)N)=CC2=CC=1N(CC1)CCN1CC1=CC=CC(Cl)=C1 UVKBMQYZNVXBGB-UHFFFAOYSA-N 0.000 description 1
• JYAJENAXHIZANC-UHFFFAOYSA-N 5-[4-[(3-chlorophenyl)methyl]piperazin-1-yl]-4-methyl-1-benzofuran-2-carboxylic acid Chemical compound C1=CC=2OC(C(O)=O)=CC=2C(C)=C1N(CC1)CCN1CC1=CC=CC(Cl)=C1 JYAJENAXHIZANC-UHFFFAOYSA-N 0.000 description 1
• AESGYIYKQPVNOH-UHFFFAOYSA-N 5-[4-[(3-chlorophenyl)methylsulfonyl]piperazin-1-yl]-4-methyl-1-benzofuran-2-carboxylic acid Chemical compound C1=CC=2OC(C(O)=O)=CC=2C(C)=C1N(CC1)CCN1S(=O)(=O)CC1=CC=CC(Cl)=C1 AESGYIYKQPVNOH-UHFFFAOYSA-N 0.000 description 1
• RHBRHQUTUIMCFF-UHFFFAOYSA-N 5-[4-[(3-fluorophenyl)methyl]piperazin-1-yl]-4-methyl-1-benzofuran-2-carboxylic acid Chemical compound C1=CC=2OC(C(O)=O)=CC=2C(C)=C1N(CC1)CCN1CC1=CC=CC(F)=C1 RHBRHQUTUIMCFF-UHFFFAOYSA-N 0.000 description 1
• QZJCCWBQBPBAHH-UHFFFAOYSA-N 5-[4-[3-(2,6-dichlorophenyl)-5-propan-2-yl-1,2-oxazole-4-carbonyl]piperazin-1-yl]-4-methyl-1-benzofuran-2-carboxylic acid Chemical compound C1CN(C=2C(=C3C=C(OC3=CC=2)C(O)=O)C)CCN1C(=O)C1=C(C(C)C)ON=C1C1=C(Cl)C=CC=C1Cl QZJCCWBQBPBAHH-UHFFFAOYSA-N 0.000 description 1
• BFQVJLIMIBLPHW-UHFFFAOYSA-N 5-[4-[[3-(2,6-dichlorophenyl)-5-propan-2-yl-1,2-oxazol-4-yl]methyl]piperazin-1-yl]-4-methyl-1-benzofuran-2-carboxylic acid Chemical compound C1CN(C=2C(=C3C=C(OC3=CC=2)C(O)=O)C)CCN1CC1=C(C(C)C)ON=C1C1=C(Cl)C=CC=C1Cl BFQVJLIMIBLPHW-UHFFFAOYSA-N 0.000 description 1
• NNEVUVBMKCKLFE-UHFFFAOYSA-N 5-[4-[[3-(trifluoromethoxy)phenyl]methyl]piperazin-1-yl]-1-benzofuran-2-carboxamide Chemical compound C=1C=C2OC(C(=O)N)=CC2=CC=1N(CC1)CCN1CC1=CC=CC(OC(F)(F)F)=C1 NNEVUVBMKCKLFE-UHFFFAOYSA-N 0.000 description 1
• BYPUMUIOKNAQOR-UHFFFAOYSA-N 5-[4-[[3-(trifluoromethyl)phenyl]methyl]piperazin-1-yl]-1-benzofuran-2-carboxamide Chemical compound C=1C=C2OC(C(=O)N)=CC2=CC=1N(CC1)CCN1CC1=CC=CC(C(F)(F)F)=C1 BYPUMUIOKNAQOR-UHFFFAOYSA-N 0.000 description 1
• XXHKQNFPSVYHBJ-UHFFFAOYSA-N 5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazole Chemical compound C1(CC1)C1=CC(=NO1)C1=C(C=CC=C1Cl)Cl XXHKQNFPSVYHBJ-UHFFFAOYSA-N 0.000 description 1
• KPBBOMNCCUQQCP-UHFFFAOYSA-N 6-[3-[2-chloro-4-[[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]methoxy]phenyl]-3-hydroxycyclobutyl]-1-methylindazole-3-carboxylic acid Chemical compound C1=C2N(C)N=C(C(O)=O)C2=CC=C1C(C1)CC1(O)C(C(=C1)Cl)=CC=C1OCC1=C(C2CC2)ON=C1C1=C(Cl)C=CC=C1Cl KPBBOMNCCUQQCP-UHFFFAOYSA-N 0.000 description 1
• 102100027211 Albumin Human genes 0.000 description 1
• 108010088751 Albumins Proteins 0.000 description 1
• QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
• 244000144725 Amygdalus communis Species 0.000 description 1
• 235000011437 Amygdalus communis Nutrition 0.000 description 1
• 101710095342 Apolipoprotein B Proteins 0.000 description 1
• 102100040202 Apolipoprotein B-100 Human genes 0.000 description 1
• 108010071619 Apolipoproteins Proteins 0.000 description 1
• 102000007592 Apolipoproteins Human genes 0.000 description 1
• 241000894006 Bacteria Species 0.000 description 1
• 239000005711 Benzoic acid Substances 0.000 description 1
• FXLDSVXLVPHPFU-UHFFFAOYSA-N BrC1=C(C=CC2=C1C=C(O2)C(=O)OCC)N1CCN(CC1)C(=O)O Chemical compound BrC1=C(C=CC2=C1C=C(O2)C(=O)OCC)N1CCN(CC1)C(=O)O FXLDSVXLVPHPFU-UHFFFAOYSA-N 0.000 description 1
• DNJVYWXIDISQRD-UHFFFAOYSA-N Cafestol Natural products C1CC2(CC3(CO)O)CC3CCC2C2(C)C1C(C=CO1)=C1CC2 DNJVYWXIDISQRD-UHFFFAOYSA-N 0.000 description 1
• 108091036055 CccDNA Proteins 0.000 description 1
• 206010008909 Chronic Hepatitis Diseases 0.000 description 1
• 108020004638 Circular DNA Proteins 0.000 description 1
• HKXRDXHEKHILEL-UHFFFAOYSA-N ClC1=C(C=CC2=C1C=C(O2)C(=O)OCC)N1CCN(CC1)C(=O)O Chemical compound ClC1=C(C=CC2=C1C=C(O2)C(=O)OCC)N1CCN(CC1)C(=O)O HKXRDXHEKHILEL-UHFFFAOYSA-N 0.000 description 1
• 102000053602 DNA Human genes 0.000 description 1
• 238000007400 DNA extraction Methods 0.000 description 1
• 230000004568 DNA-binding Effects 0.000 description 1
• 101100202237 Danio rerio rxrab gene Proteins 0.000 description 1
• 101100309320 Danio rerio rxrga gene Proteins 0.000 description 1
• 102000016911 Deoxyribonucleases Human genes 0.000 description 1
• 108010053770 Deoxyribonucleases Proteins 0.000 description 1
• XQSPYNMVSIKCOC-NTSWFWBYSA-N Emtricitabine Chemical compound C1=C(F)C(N)=NC(=O)N1[C@H]1O[C@@H](CO)SC1 XQSPYNMVSIKCOC-NTSWFWBYSA-N 0.000 description 1
• 101710142246 External core antigen Proteins 0.000 description 1
• 206010016654 Fibrosis Diseases 0.000 description 1
• 241000233866 Fungi Species 0.000 description 1
• 108010010803 Gelatin Proteins 0.000 description 1
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
• 108091005904 Hemoglobin subunit beta Proteins 0.000 description 1
• 206010019663 Hepatic failure Diseases 0.000 description 1
• 208000037262 Hepatitis delta Diseases 0.000 description 1
• 101000603962 Homo sapiens Oxysterols receptor LXR-alpha Proteins 0.000 description 1
• LENZDBCJOHFCAS-UHFFFAOYSA-O Htris Chemical compound OCC([NH3+])(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-O 0.000 description 1
• 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
• 101100512060 Hypocrea jecorina (strain QM6a) lxr3 gene Proteins 0.000 description 1
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
• 108010015268 Integration Host Factors Proteins 0.000 description 1
• HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
• 101710173438 Late L2 mu core protein Proteins 0.000 description 1
• 108090001030 Lipoproteins Proteins 0.000 description 1
• 102000004895 Lipoproteins Human genes 0.000 description 1
• 206010067125 Liver injury Diseases 0.000 description 1
• 241001465754 Metazoa Species 0.000 description 1
• YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Natural products C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 1
• FWQUWWAZWOKNDQ-UHFFFAOYSA-N N-cyclohexyl-2-[2-(4-hydroxyphenyl)benzimidazol-1-yl]-4-methylpentanamide Chemical compound C=1C=C(O)C=CC=1C1=NC2=CC=CC=C2N1C(CC(C)C)C(=O)NC1CCCCC1 FWQUWWAZWOKNDQ-UHFFFAOYSA-N 0.000 description 1
• NJVLAZLDOMVWOH-UHFFFAOYSA-N N-cyclohexyl-2-[2-(4-hydroxyphenyl)benzimidazol-1-yl]-4-methylpentanamide hydron chloride Chemical compound Cl.C1(CCCCC1)NC(C(CC(C)C)N1C(=NC2=C1C=CC=C2)C2=CC=C(C=C2)O)=O NJVLAZLDOMVWOH-UHFFFAOYSA-N 0.000 description 1
• 102100038476 Oxysterols receptor LXR-alpha Human genes 0.000 description 1
• 101150014691 PPARA gene Proteins 0.000 description 1
• 235000019483 Peanut oil Nutrition 0.000 description 1
• 102100022428 Phospholipid transfer protein Human genes 0.000 description 1
• 101150050070 RXRA gene Proteins 0.000 description 1
• 108091027981 Response element Proteins 0.000 description 1
• KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
• 101710120037 Toxin CcdB Proteins 0.000 description 1
• NYUZEPZYXJQFRP-UHFFFAOYSA-N [4-bromo-5-[4-(2,6-dichlorobenzoyl)-1,4-diazepan-1-yl]-1-benzofuran-2-yl]-piperidin-1-ylmethanone Chemical compound ClC1=CC=CC(Cl)=C1C(=O)N1CCN(C=2C(=C3C=C(OC3=CC=2)C(=O)N2CCCCC2)Br)CCC1 NYUZEPZYXJQFRP-UHFFFAOYSA-N 0.000 description 1
• HJYQHOOZDIOZPY-UHFFFAOYSA-N [4-bromo-5-[4-(2,6-dichlorophenyl)sulfonylpiperazin-1-yl]-1-benzofuran-2-yl]-(4-methylpiperazin-1-yl)methanone Chemical compound C1CN(C)CCN1C(=O)C1=CC2=C(Br)C(N3CCN(CC3)S(=O)(=O)C=3C(=CC=CC=3Cl)Cl)=CC=C2O1 HJYQHOOZDIOZPY-UHFFFAOYSA-N 0.000 description 1
• LOFCKUDMPOAKAE-UHFFFAOYSA-N [4-bromo-5-[4-(2-chlorophenyl)sulfonylpiperazin-1-yl]-1-benzofuran-2-yl]-morpholin-4-ylmethanone;4-bromo-5-[[1-(3-chlorophenyl)sulfonylpiperidin-4-yl]amino]-1-benzofuran-2-carboxylic acid Chemical compound C=1C=C2OC(C(=O)O)=CC2=C(Br)C=1NC(CC1)CCN1S(=O)(=O)C1=CC=CC(Cl)=C1.ClC1=CC=CC=C1S(=O)(=O)N1CCN(C=2C(=C3C=C(OC3=CC=2)C(=O)N2CCOCC2)Br)CC1 LOFCKUDMPOAKAE-UHFFFAOYSA-N 0.000 description 1
• OOCSZMGEGYBQFT-UHFFFAOYSA-N [4-chloro-5-[4-(2,3-dichlorophenyl)sulfonyl-1,4-diazepan-1-yl]-1-benzofuran-2-yl]-morpholin-4-ylmethanone Chemical compound ClC1=CC=CC(S(=O)(=O)N2CCN(CCC2)C=2C(=C3C=C(OC3=CC=2)C(=O)N2CCOCC2)Cl)=C1Cl OOCSZMGEGYBQFT-UHFFFAOYSA-N 0.000 description 1
• WEMMLYSFKVPXCE-UHFFFAOYSA-N [4-chloro-5-[4-(2,3-dichlorophenyl)sulfonylpiperazin-1-yl]-1-benzofuran-2-yl]-morpholin-4-ylmethanone Chemical compound ClC1=CC=CC(S(=O)(=O)N2CCN(CC2)C=2C(=C3C=C(OC3=CC=2)C(=O)N2CCOCC2)Cl)=C1Cl WEMMLYSFKVPXCE-UHFFFAOYSA-N 0.000 description 1
• ZPCYNDYONILBAL-UHFFFAOYSA-N [4-chloro-5-[4-(2,5-dichlorophenyl)sulfonyl-1,4-diazepan-1-yl]-1-benzofuran-2-yl]-morpholin-4-ylmethanone Chemical compound ClC1=CC=C(Cl)C(S(=O)(=O)N2CCN(CCC2)C=2C(=C3C=C(OC3=CC=2)C(=O)N2CCOCC2)Cl)=C1 ZPCYNDYONILBAL-UHFFFAOYSA-N 0.000 description 1
• PPZKOIGFEXYTEC-UHFFFAOYSA-N [4-chloro-5-[4-(2,6-dichlorophenyl)sulfonyl-1,4-diazepan-1-yl]-1-benzofuran-2-yl]-morpholin-4-ylmethanone Chemical compound ClC1=CC=CC(Cl)=C1S(=O)(=O)N1CCN(C=2C(=C3C=C(OC3=CC=2)C(=O)N2CCOCC2)Cl)CCC1 PPZKOIGFEXYTEC-UHFFFAOYSA-N 0.000 description 1
• WKTIZLFXIHBYBE-UHFFFAOYSA-N [5-[4-[(2,6-dichlorophenyl)methyl]-1,4-diazepan-1-yl]-4-methyl-1-benzofuran-2-yl]-(4-methylpiperazin-1-yl)methanone Chemical compound C1CN(C)CCN1C(=O)C1=CC2=C(C)C(N3CCN(CC=4C(=CC=CC=4Cl)Cl)CCC3)=CC=C2O1 WKTIZLFXIHBYBE-UHFFFAOYSA-N 0.000 description 1
• 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 1
• 150000007513 acids Chemical class 0.000 description 1
• 239000012190 activator Substances 0.000 description 1
• 230000001154 acute effect Effects 0.000 description 1
• 230000002411 adverse Effects 0.000 description 1
• 239000000443 aerosol Substances 0.000 description 1
• 230000000172 allergic effect Effects 0.000 description 1
• 235000020224 almond Nutrition 0.000 description 1
• 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
• 150000001408 amides Chemical class 0.000 description 1
• 125000003277 amino group Chemical group 0.000 description 1
• 235000011114 ammonium hydroxide Nutrition 0.000 description 1
• 239000003242 anti bacterial agent Substances 0.000 description 1
• 230000000844 anti-bacterial effect Effects 0.000 description 1
• 239000003429 antifungal agent Substances 0.000 description 1
• 229940121375 antifungal agent Drugs 0.000 description 1
• 239000012736 aqueous medium Substances 0.000 description 1
• 208000010668 atopic eczema Diseases 0.000 description 1
• XYOVOXDWRFGKEX-UHFFFAOYSA-N azepine Chemical compound N1C=CC=CC=C1 XYOVOXDWRFGKEX-UHFFFAOYSA-N 0.000 description 1
• 230000004888 barrier function Effects 0.000 description 1
• 235000010233 benzoic acid Nutrition 0.000 description 1
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
• 229920002988 biodegradable polymer Polymers 0.000 description 1
• 239000004621 biodegradable polymer Substances 0.000 description 1
• 210000004899 c-terminal region Anatomy 0.000 description 1
• DNJVYWXIDISQRD-JTSSGKSMSA-N cafestol Chemical compound C([C@H]1C[C@]2(C[C@@]1(CO)O)CC1)C[C@H]2[C@@]2(C)[C@H]1C(C=CO1)=C1CC2 DNJVYWXIDISQRD-JTSSGKSMSA-N 0.000 description 1
• 239000011575 calcium Substances 0.000 description 1
• 229910052791 calcium Inorganic materials 0.000 description 1
• 239000001110 calcium chloride Substances 0.000 description 1
• 229910001628 calcium chloride Inorganic materials 0.000 description 1
• 235000011116 calcium hydroxide Nutrition 0.000 description 1
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
• 230000030833 cell death Effects 0.000 description 1
• 239000013592 cell lysate Substances 0.000 description 1
• 210000000170 cell membrane Anatomy 0.000 description 1
• 210000003855 cell nucleus Anatomy 0.000 description 1
• 230000007969 cellular immunity Effects 0.000 description 1
• 229940047583 cetamide Drugs 0.000 description 1
• 230000008859 change Effects 0.000 description 1
• 229960004926 chlorobutanol Drugs 0.000 description 1
• 230000007882 cirrhosis Effects 0.000 description 1
• 208000019425 cirrhosis of liver Diseases 0.000 description 1
• 239000011248 coating agent Substances 0.000 description 1
• 238000000576 coating method Methods 0.000 description 1
• 238000011284 combination treatment Methods 0.000 description 1
• 238000011340 continuous therapy Methods 0.000 description 1
• 239000012531 culture fluid Substances 0.000 description 1
• 239000012228 culture supernatant Substances 0.000 description 1
• 238000009109 curative therapy Methods 0.000 description 1
• BYUYRWRYAISPPF-UHFFFAOYSA-N cyclobutyloxycyclobutane Chemical compound C1CCC1OC1CCC1 BYUYRWRYAISPPF-UHFFFAOYSA-N 0.000 description 1
• UKJLNMAFNRKWGR-UHFFFAOYSA-N cyclohexatrienamine Chemical group NC1=CC=C=C[CH]1 UKJLNMAFNRKWGR-UHFFFAOYSA-N 0.000 description 1
• 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
• 229930182912 cyclosporin Natural products 0.000 description 1
• 230000000120 cytopathologic effect Effects 0.000 description 1
• 210000000805 cytoplasm Anatomy 0.000 description 1
• 101150047356 dec-1 gene Proteins 0.000 description 1
• 238000000326 densiometry Methods 0.000 description 1
• 229940009976 deoxycholate Drugs 0.000 description 1
• KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 description 1
• 230000001419 dependent effect Effects 0.000 description 1
• 238000003745 diagnosis Methods 0.000 description 1
• 235000005911 diet Nutrition 0.000 description 1
• 230000037213 diet Effects 0.000 description 1
• 230000004069 differentiation Effects 0.000 description 1
• UGMCXQCYOVCMTB-UHFFFAOYSA-K dihydroxy(stearato)aluminium Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[Al](O)O UGMCXQCYOVCMTB-UHFFFAOYSA-K 0.000 description 1
• 238000011979 disease modifying therapy Methods 0.000 description 1
• BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
• 229910000397 disodium phosphate Inorganic materials 0.000 description 1
• 235000019800 disodium phosphate Nutrition 0.000 description 1
• 238000009826 distribution Methods 0.000 description 1
• 150000004141 diterpene derivatives Chemical class 0.000 description 1
• 239000003937 drug carrier Substances 0.000 description 1
• 230000000531 effect on virus Effects 0.000 description 1
• 229960000366 emtricitabine Drugs 0.000 description 1
• 239000003623 enhancer Substances 0.000 description 1
• 150000002148 esters Chemical class 0.000 description 1
• BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
• PBOYGYXGAGTCMY-UHFFFAOYSA-N ethyl 1h-azepine-4-carboxylate Chemical compound CCOC(=O)C1=CC=CNC=C1 PBOYGYXGAGTCMY-UHFFFAOYSA-N 0.000 description 1
• YCLRYOIIPVEBMX-UHFFFAOYSA-N ethyl 3-(3,4-difluorobenzoyl)-1,1,6-trimethyl-2h-azepino[4,5-b]indole-5-carboxylate Chemical compound C1C(C)(C)C(C2=CC=CC=C2N2C)=C2C(C(=O)OCC)=CN1C(=O)C1=CC=C(F)C(F)=C1 YCLRYOIIPVEBMX-UHFFFAOYSA-N 0.000 description 1
• AAGAYUABSBAYSC-UHFFFAOYSA-N ethyl 3-(3,4-difluorobenzoyl)-1-methyl-2,6-dihydro-1h-azepino[4,5-b]indole-5-carboxylate Chemical compound C1C(C)C(C2=CC=CC=C2N2)=C2C(C(=O)OCC)=CN1C(=O)C1=CC=C(F)C(F)=C1 AAGAYUABSBAYSC-UHFFFAOYSA-N 0.000 description 1
• ZHZMJJCSWCTTJO-UHFFFAOYSA-N ethyl 3-(3,4-difluorobenzoyl)-9-fluoro-1,1-dimethyl-2,6-dihydroazepino[4,5-b]indole-5-carboxylate Chemical compound C1C(C)(C)C(C2=CC(F)=CC=C2N2)=C2C(C(=O)OCC)=CN1C(=O)C1=CC=C(F)C(F)=C1 ZHZMJJCSWCTTJO-UHFFFAOYSA-N 0.000 description 1
• TZNQYNGMIPZHKJ-UHFFFAOYSA-N ethyl 3-(3-fluorobenzoyl)-2,6-dihydro-1h-azepino[4,5-b]indole-5-carboxylate Chemical compound C1CC(C2=CC=CC=C2N2)=C2C(C(=O)OCC)=CN1C(=O)C1=CC=CC(F)=C1 TZNQYNGMIPZHKJ-UHFFFAOYSA-N 0.000 description 1
• OSEILIMCSUKCSZ-UHFFFAOYSA-N ethyl 3-(4-chlorobenzoyl)-1,1-dimethyl-2,6-dihydroazepino[4,5-b]indole-5-carboxylate Chemical compound C1C(C)(C)C(C2=CC=CC=C2N2)=C2C(C(=O)OCC)=CN1C(=O)C1=CC=C(Cl)C=C1 OSEILIMCSUKCSZ-UHFFFAOYSA-N 0.000 description 1
• KGLPNKZEJPFLFT-UHFFFAOYSA-N ethyl 3-(4-chlorobenzoyl)-1-methyl-2,6-dihydro-1h-azepino[4,5-b]indole-5-carboxylate Chemical compound C1C(C)C(C2=CC=CC=C2N2)=C2C(C(=O)OCC)=CN1C(=O)C1=CC=C(Cl)C=C1 KGLPNKZEJPFLFT-UHFFFAOYSA-N 0.000 description 1
• RIOOYHSIGBIHCB-UHFFFAOYSA-N ethyl 3-(4-fluorobenzoyl)-1,1-dimethyl-2,4,5,6,7,8,9,10-octahydroazepino[4,5-b]indole-5-carboxylate Chemical compound C1C(C)(C)C=2C=3CCCCC=3NC=2C(C(=O)OCC)CN1C(=O)C1=CC=C(F)C=C1 RIOOYHSIGBIHCB-UHFFFAOYSA-N 0.000 description 1
• DIPPMWSNAUWPLJ-UHFFFAOYSA-N ethyl 3-(4-fluorobenzoyl)-1,1-dimethyl-9-[(2-phenylacetyl)amino]-2,6-dihydroazepino[4,5-b]indole-5-carboxylate Chemical compound CCOC(=O)C1=CN(C(=O)C=2C=CC(F)=CC=2)CC(C)(C)C(C2=C3)=C1NC2=CC=C3NC(=O)CC1=CC=CC=C1 DIPPMWSNAUWPLJ-UHFFFAOYSA-N 0.000 description 1
• MVYSSTPZWAVKFN-UHFFFAOYSA-N ethyl 3-(4-fluorobenzoyl)-1-methyl-2,6-dihydro-1h-azepino[4,5-b]indole-5-carboxylate Chemical compound C1C(C)C(C2=CC=CC=C2N2)=C2C(C(=O)OCC)=CN1C(=O)C1=CC=C(F)C=C1 MVYSSTPZWAVKFN-UHFFFAOYSA-N 0.000 description 1
• UAKXBPBHABHUMZ-UHFFFAOYSA-N ethyl 3-(4-fluorobenzoyl)-2,4,5,6,7,8,9,10-octahydro-1h-azepino[4,5-b]indole-5-carboxylate Chemical compound C1CC=2C=3CCCCC=3NC=2C(C(=O)OCC)CN1C(=O)C1=CC=C(F)C=C1 UAKXBPBHABHUMZ-UHFFFAOYSA-N 0.000 description 1
• WEMWNNNXMBXARK-UHFFFAOYSA-N ethyl 3-(4-fluorobenzoyl)-2,6,7,8,9,10-hexahydro-1h-azepino[4,5-b]indole-5-carboxylate Chemical compound C1CC=2C=3CCCCC=3NC=2C(C(=O)OCC)=CN1C(=O)C1=CC=C(F)C=C1 WEMWNNNXMBXARK-UHFFFAOYSA-N 0.000 description 1
• OBGFIJHGDTXLPB-UHFFFAOYSA-N ethyl 3-(4-fluorobenzoyl)-2,6-dihydro-1h-azepino[4,5-b]indole-5-carboxylate Chemical compound C1CC(C2=CC=CC=C2N2)=C2C(C(=O)OCC)=CN1C(=O)C1=CC=C(F)C=C1 OBGFIJHGDTXLPB-UHFFFAOYSA-N 0.000 description 1
• RFPSUZMUBCQDIF-UHFFFAOYSA-N ethyl 9-[acetyl(methyl)amino]-3-(4-fluorobenzoyl)-1,1-dimethyl-2,6-dihydroazepino[4,5-b]indole-5-carboxylate Chemical compound C1C(C)(C)C(C2=CC(=CC=C2N2)N(C)C(C)=O)=C2C(C(=O)OCC)=CN1C(=O)C1=CC=C(F)C=C1 RFPSUZMUBCQDIF-UHFFFAOYSA-N 0.000 description 1
• WVZPOEOGTQICJW-UHFFFAOYSA-N ethyl 9-[benzyl-(2-thiophen-2-ylacetyl)amino]-3-(4-fluorobenzoyl)-1,1-dimethyl-2,6-dihydroazepino[4,5-b]indole-5-carboxylate Chemical compound CCOC(=O)C1=CN(C(=O)C=2C=CC(F)=CC=2)CC(C)(C)C(C2=C3)=C1NC2=CC=C3N(C(=O)CC=1SC=CC=1)CC1=CC=CC=C1 WVZPOEOGTQICJW-UHFFFAOYSA-N 0.000 description 1
• DYTPYGNJKOZSLQ-UHFFFAOYSA-N ethyl 9-fluoro-3-(4-fluorobenzoyl)-1,1-dimethyl-2,6-dihydroazepino[4,5-b]indole-5-carboxylate Chemical compound C1C(C)(C)C(C2=CC(F)=CC=C2N2)=C2C(C(=O)OCC)=CN1C(=O)C1=CC=C(F)C=C1 DYTPYGNJKOZSLQ-UHFFFAOYSA-N 0.000 description 1
• 238000011156 evaluation Methods 0.000 description 1
• 230000029142 excretion Effects 0.000 description 1
• 229940043259 farnesol Drugs 0.000 description 1
• 229930002886 farnesol Natural products 0.000 description 1
• RWTNPBWLLIMQHL-UHFFFAOYSA-N fexofenadine Chemical compound C1=CC(C(C)(C(O)=O)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 RWTNPBWLLIMQHL-UHFFFAOYSA-N 0.000 description 1
• 239000000945 filler Substances 0.000 description 1
• 238000001914 filtration Methods 0.000 description 1
• 238000000799 fluorescence microscopy Methods 0.000 description 1
• 238000009472 formulation Methods 0.000 description 1
• 229920000159 gelatin Polymers 0.000 description 1
• 239000008273 gelatin Substances 0.000 description 1
• 239000007903 gelatin capsule Substances 0.000 description 1
• 235000019322 gelatine Nutrition 0.000 description 1
• 235000011852 gelatine desserts Nutrition 0.000 description 1
• 239000008103 glucose Substances 0.000 description 1
• 239000008187 granular material Substances 0.000 description 1
• 230000012010 growth Effects 0.000 description 1
• 239000001963 growth medium Substances 0.000 description 1
• 231100000234 hepatic damage Toxicity 0.000 description 1
• 230000002440 hepatic effect Effects 0.000 description 1
• 108010011891 hepatitis B surface antigen receptor Proteins 0.000 description 1
• 239000000833 heterodimer Substances 0.000 description 1
• HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
• 230000013632 homeostatic process Effects 0.000 description 1
• BXOBMCQSINFEBT-UHFFFAOYSA-N hydron;methyl 4-[1-[1-cyclohexyl-2-(3-formamidoanilino)-2-oxoethyl]benzimidazol-2-yl]benzoate;chloride Chemical compound Cl.C1=CC(C(=O)OC)=CC=C1C1=NC2=CC=CC=C2N1C(C(=O)NC=1C=C(NC=O)C=CC=1)C1CCCCC1 BXOBMCQSINFEBT-UHFFFAOYSA-N 0.000 description 1
• RQTMKOXKRMLVFL-UHFFFAOYSA-N hydron;methyl 4-[1-[1-cyclohexyl-2-(4-morpholin-4-ylanilino)-2-oxoethyl]benzimidazol-2-yl]benzoate;chloride Chemical compound Cl.C1=CC(C(=O)OC)=CC=C1C1=NC2=CC=CC=C2N1C(C(=O)NC=1C=CC(=CC=1)N1CCOCC1)C1CCCCC1 RQTMKOXKRMLVFL-UHFFFAOYSA-N 0.000 description 1
• 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
• 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
• 230000006058 immune tolerance Effects 0.000 description 1
• 238000003018 immunoassay Methods 0.000 description 1
• 238000010166 immunofluorescence Methods 0.000 description 1
• 238000003364 immunohistochemistry Methods 0.000 description 1
• 239000007943 implant Substances 0.000 description 1
• 238000001802 infusion Methods 0.000 description 1
• 238000011221 initial treatment Methods 0.000 description 1
• 150000007529 inorganic bases Chemical class 0.000 description 1
• 230000003834 intracellular effect Effects 0.000 description 1
• 238000010255 intramuscular injection Methods 0.000 description 1
• 239000007927 intramuscular injection Substances 0.000 description 1
• 238000010253 intravenous injection Methods 0.000 description 1
• 235000014413 iron hydroxide Nutrition 0.000 description 1
• NCNCGGDMXMBVIA-UHFFFAOYSA-L iron(ii) hydroxide Chemical class [OH-].[OH-].[Fe+2] NCNCGGDMXMBVIA-UHFFFAOYSA-L 0.000 description 1
• 239000007951 isotonicity adjuster Substances 0.000 description 1
• 230000007775 late Effects 0.000 description 1
• 239000000787 lecithin Substances 0.000 description 1
• 235000010445 lecithin Nutrition 0.000 description 1
• 229940067606 lecithin Drugs 0.000 description 1
• 230000000670 limiting effect Effects 0.000 description 1
• 238000012317 liver biopsy Methods 0.000 description 1
• 210000005229 liver cell Anatomy 0.000 description 1
• 230000008818 liver damage Effects 0.000 description 1
• 231100000835 liver failure Toxicity 0.000 description 1
• 208000007903 liver failure Diseases 0.000 description 1
• 208000018191 liver inflammation Diseases 0.000 description 1
• 238000011866 long-term treatment Methods 0.000 description 1
• 230000007774 longterm Effects 0.000 description 1
• 229910001629 magnesium chloride Inorganic materials 0.000 description 1
• 239000000463 material Substances 0.000 description 1
• 239000011159 matrix material Substances 0.000 description 1
• 230000007246 mechanism Effects 0.000 description 1
• 230000010534 mechanism of action Effects 0.000 description 1
• 230000001404 mediated effect Effects 0.000 description 1
• OJURWUUOVGOHJZ-UHFFFAOYSA-N methyl 2-[(2-acetyloxyphenyl)methyl-[2-[(2-acetyloxyphenyl)methyl-(2-methoxy-2-oxoethyl)amino]ethyl]amino]acetate Chemical compound C=1C=CC=C(OC(C)=O)C=1CN(CC(=O)OC)CCN(CC(=O)OC)CC1=CC=CC=C1OC(C)=O OJURWUUOVGOHJZ-UHFFFAOYSA-N 0.000 description 1
• MKAWXVIRBFFYOH-UHFFFAOYSA-N methyl 2-[6-chloro-1-[1-cyclohexyl-2-(cyclohexylamino)-2-oxoethyl]-5-fluorobenzimidazol-2-yl]benzoate Chemical compound COC(=O)C1=CC=CC=C1C1=NC2=CC(F)=C(Cl)C=C2N1C(C(=O)NC1CCCCC1)C1CCCCC1 MKAWXVIRBFFYOH-UHFFFAOYSA-N 0.000 description 1
• HRPZFBFXCFPGGK-UHFFFAOYSA-N methyl 3-[1-[2-(benzylamino)-1-cyclopentyl-2-oxoethyl]benzimidazol-2-yl]benzoate Chemical compound COC(=O)C1=CC=CC(C=2N(C3=CC=CC=C3N=2)C(C2CCCC2)C(=O)NCC=2C=CC=CC=2)=C1 HRPZFBFXCFPGGK-UHFFFAOYSA-N 0.000 description 1
• OAMMFYMXQZUXPT-UHFFFAOYSA-N methyl 4-[1-[1-(2-fluorophenyl)-2-oxo-2-(propan-2-ylamino)ethyl]benzimidazol-2-yl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1C1=NC2=CC=CC=C2N1C(C(=O)NC(C)C)C1=CC=CC=C1F OAMMFYMXQZUXPT-UHFFFAOYSA-N 0.000 description 1
• MAAZUNMIZGMECR-UHFFFAOYSA-N methyl 4-[1-[1-(4-methoxyphenyl)-2-oxo-2-(propan-2-ylamino)ethyl]benzimidazol-2-yl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1C1=NC2=CC=CC=C2N1C(C(=O)NC(C)C)C1=CC=C(OC)C=C1 MAAZUNMIZGMECR-UHFFFAOYSA-N 0.000 description 1
• ACWFBVRAXQEQRL-UHFFFAOYSA-N methyl 4-[1-[1-(benzylamino)-1-oxo-4-phenylbutan-2-yl]benzimidazol-2-yl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1C1=NC2=CC=CC=C2N1C(C(=O)NCC=1C=CC=CC=1)CCC1=CC=CC=C1 ACWFBVRAXQEQRL-UHFFFAOYSA-N 0.000 description 1
• NFHWJHVNZSJAGS-UHFFFAOYSA-N methyl 4-[1-[1-(cyclohexylamino)-1-oxo-4-phenylbutan-2-yl]benzimidazol-2-yl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1C1=NC2=CC=CC=C2N1C(C(=O)NC1CCCCC1)CCC1=CC=CC=C1 NFHWJHVNZSJAGS-UHFFFAOYSA-N 0.000 description 1
• TUFRZQZFZZQMGY-UHFFFAOYSA-N methyl 4-[1-[1-(cyclopentylamino)-1-oxo-4-phenylbutan-2-yl]benzimidazol-2-yl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1C1=NC2=CC=CC=C2N1C(C(=O)NC1CCCC1)CCC1=CC=CC=C1 TUFRZQZFZZQMGY-UHFFFAOYSA-N 0.000 description 1
• NGJOFBONCQKHOF-UHFFFAOYSA-N methyl 4-[1-[1-cyclohexyl-2-(cyclohexylamino)-2-oxoethyl]benzimidazol-2-yl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1C1=NC2=CC=CC=C2N1C(C(=O)NC1CCCCC1)C1CCCCC1 NGJOFBONCQKHOF-UHFFFAOYSA-N 0.000 description 1
• NVSGDEPGKVFUSJ-UHFFFAOYSA-N methyl 4-[1-[1-oxo-1-(propan-2-ylamino)hexan-2-yl]benzimidazol-2-yl]benzoate Chemical compound N=1C2=CC=CC=C2N(C(C(=O)NC(C)C)CCCC)C=1C1=CC=C(C(=O)OC)C=C1 NVSGDEPGKVFUSJ-UHFFFAOYSA-N 0.000 description 1
• CANXCAICXDAVQK-UHFFFAOYSA-N methyl 4-[1-[2-(benzylamino)-1-cyclopentyl-2-oxoethyl]benzimidazol-2-yl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1C1=NC2=CC=CC=C2N1C(C(=O)NCC=1C=CC=CC=1)C1CCCC1 CANXCAICXDAVQK-UHFFFAOYSA-N 0.000 description 1
• XXTIHDGDXKXMHS-UHFFFAOYSA-N methyl 4-[1-[2-oxo-1-phenyl-2-(propan-2-ylamino)ethyl]benzimidazol-2-yl]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1C1=NC2=CC=CC=C2N1C(C(=O)NC(C)C)C1=CC=CC=C1 XXTIHDGDXKXMHS-UHFFFAOYSA-N 0.000 description 1
• MZDGXTXYHXDWIM-UHFFFAOYSA-N methyl benzoate;hydrochloride Chemical compound Cl.COC(=O)C1=CC=CC=C1 MZDGXTXYHXDWIM-UHFFFAOYSA-N 0.000 description 1
• 150000007522 mineralic acids Chemical class 0.000 description 1
• 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
• 235000019799 monosodium phosphate Nutrition 0.000 description 1
• 238000010172 mouse model Methods 0.000 description 1
• VMISWNVQSXAGBF-UHFFFAOYSA-N n,2-dicyclohexyl-2-(2-naphthalen-2-ylbenzimidazol-1-yl)acetamide Chemical compound C1CCCCC1C(N1C2=CC=CC=C2N=C1C=1C=C2C=CC=CC2=CC=1)C(=O)NC1CCCCC1 VMISWNVQSXAGBF-UHFFFAOYSA-N 0.000 description 1
• PXHWDZZLPDRDGS-UHFFFAOYSA-N n,2-dicyclohexyl-2-(2-quinolin-4-ylbenzimidazol-1-yl)acetamide Chemical compound C1CCCCC1C(N1C2=CC=CC=C2N=C1C=1C2=CC=CC=C2N=CC=1)C(=O)NC1CCCCC1 PXHWDZZLPDRDGS-UHFFFAOYSA-N 0.000 description 1
• NDMKDQHQRCSDFW-UHFFFAOYSA-N n,2-dicyclohexyl-2-(6-fluoro-2-pyridin-2-ylbenzimidazol-1-yl)acetamide Chemical compound C1CCCCC1C(C(=O)NC1CCCCC1)N1C2=CC(F)=CC=C2N=C1C1=CC=CC=N1 NDMKDQHQRCSDFW-UHFFFAOYSA-N 0.000 description 1
• VVBXNLMQSLOQGH-UHFFFAOYSA-N n-benzyl-2-cyclohexyl-2-[2-(2,4-dimethoxyphenyl)benzimidazol-1-yl]acetamide Chemical compound COC1=CC(OC)=CC=C1C1=NC2=CC=CC=C2N1C(C(=O)NCC=1C=CC=CC=1)C1CCCCC1 VVBXNLMQSLOQGH-UHFFFAOYSA-N 0.000 description 1
• MOLIWRJAUNPRKZ-UHFFFAOYSA-N n-benzyl-4-bromo-5-[4-(2-chlorophenyl)sulfonylpiperazin-1-yl]-1-benzofuran-2-carboxamide Chemical compound ClC1=CC=CC=C1S(=O)(=O)N1CCN(C=2C(=C3C=C(OC3=CC=2)C(=O)NCC=2C=CC=CC=2)Br)CC1 MOLIWRJAUNPRKZ-UHFFFAOYSA-N 0.000 description 1
• JSZRZSUOEBWMIN-UHFFFAOYSA-N n-butyl-2-[2-(2,3-dimethoxyphenyl)benzimidazol-1-yl]-2-(2-methylphenyl)acetamide Chemical compound C=1C=CC(OC)=C(OC)C=1C1=NC2=CC=CC=C2N1C(C(=O)NCCCC)C1=CC=CC=C1C JSZRZSUOEBWMIN-UHFFFAOYSA-N 0.000 description 1
• KXOAUGQPXPZMFG-UHFFFAOYSA-N n-cyclobutyl-3-(3,4-difluorobenzoyl)-1-methyl-2,6-dihydro-1h-azepino[4,5-b]indole-5-carboxamide Chemical compound C1=2NC3=CC=CC=C3C=2C(C)CN(C(=O)C=2C=C(F)C(F)=CC=2)C=C1C(=O)NC1CCC1 KXOAUGQPXPZMFG-UHFFFAOYSA-N 0.000 description 1
• NDRAMBTXSQBBKG-UHFFFAOYSA-N n-cyclobutyl-3-(3,4-difluorobenzoyl)-2-methyl-2,6-dihydro-1h-azepino[4,5-b]indole-5-carboxamide Chemical compound CC1CC(C2=CC=CC=C2N2)=C2C(C(=O)NC2CCC2)=CN1C(=O)C1=CC=C(F)C(F)=C1 NDRAMBTXSQBBKG-UHFFFAOYSA-N 0.000 description 1
• UNIYMUKDMOFJDT-UHFFFAOYSA-N n-cyclobutyl-3-(4-fluorobenzoyl)-2-methyl-2,6-dihydro-1h-azepino[4,5-b]indole-5-carboxamide Chemical compound CC1CC(C2=CC=CC=C2N2)=C2C(C(=O)NC2CCC2)=CN1C(=O)C1=CC=C(F)C=C1 UNIYMUKDMOFJDT-UHFFFAOYSA-N 0.000 description 1
• RUYCYFOJTMBTJJ-UHFFFAOYSA-N n-cyclohexyl-2-[2-(1h-indol-5-yl)benzimidazol-1-yl]-4-methylpentanamide Chemical compound C=1C=C2NC=CC2=CC=1C1=NC2=CC=CC=C2N1C(CC(C)C)C(=O)NC1CCCCC1 RUYCYFOJTMBTJJ-UHFFFAOYSA-N 0.000 description 1
• AOMOILWMSNZMOS-UHFFFAOYSA-N n-cyclohexyl-2-[2-(1h-indol-6-yl)benzimidazol-1-yl]-4-methylpentanamide Chemical compound C=1C=C2C=CNC2=CC=1C1=NC2=CC=CC=C2N1C(CC(C)C)C(=O)NC1CCCCC1 AOMOILWMSNZMOS-UHFFFAOYSA-N 0.000 description 1
• IFXJGODIOVCGOY-UHFFFAOYSA-N n-cyclohexyl-2-[2-(2,3-dimethoxyphenyl)benzimidazol-1-yl]-4-methylpentanamide Chemical compound COC1=CC=CC(C=2N(C3=CC=CC=C3N=2)C(CC(C)C)C(=O)NC2CCCCC2)=C1OC IFXJGODIOVCGOY-UHFFFAOYSA-N 0.000 description 1
• YTHBVZPSYIQIBW-UHFFFAOYSA-N n-cyclohexyl-2-[2-(2,4-dimethoxyphenyl)benzimidazol-1-yl]-2-phenylacetamide;hydron;chloride Chemical compound Cl.COC1=CC(OC)=CC=C1C1=NC2=CC=CC=C2N1C(C=1C=CC=CC=1)C(=O)NC1CCCCC1 YTHBVZPSYIQIBW-UHFFFAOYSA-N 0.000 description 1
• GEJSAIBHFXXVKM-UHFFFAOYSA-N n-cyclohexyl-2-[2-(2,4-dimethoxyphenyl)benzimidazol-1-yl]-4-methylpentanamide Chemical compound COC1=CC(OC)=CC=C1C1=NC2=CC=CC=C2N1C(CC(C)C)C(=O)NC1CCCCC1 GEJSAIBHFXXVKM-UHFFFAOYSA-N 0.000 description 1
• VKRJQAUIZGAFOJ-UHFFFAOYSA-N n-cyclohexyl-2-[2-(2,4-dimethoxyphenyl)benzimidazol-1-yl]-4-phenylbutanamide Chemical compound COC1=CC(OC)=CC=C1C1=NC2=CC=CC=C2N1C(C(=O)NC1CCCCC1)CCC1=CC=CC=C1 VKRJQAUIZGAFOJ-UHFFFAOYSA-N 0.000 description 1
• YTBODTRRLUVRQS-UHFFFAOYSA-N n-cyclohexyl-2-[2-(2,4-dimethoxyphenyl)benzimidazol-1-yl]-5-phenylpentanamide;hydron;chloride Chemical compound Cl.COC1=CC(OC)=CC=C1C1=NC2=CC=CC=C2N1C(C(=O)NC1CCCCC1)CCCC1=CC=CC=C1 YTBODTRRLUVRQS-UHFFFAOYSA-N 0.000 description 1
• QGLKBLCTBKYFED-UHFFFAOYSA-N n-cyclohexyl-2-[2-(2,4-dimethoxyphenyl)benzimidazol-1-yl]hexanamide Chemical compound C=1C=C(OC)C=C(OC)C=1C1=NC2=CC=CC=C2N1C(CCCC)C(=O)NC1CCCCC1 QGLKBLCTBKYFED-UHFFFAOYSA-N 0.000 description 1
• ZTAROZANANJWTE-UHFFFAOYSA-N n-cyclohexyl-2-[2-(3-hydroxyphenyl)benzimidazol-1-yl]-4-methylpentanamide Chemical compound C=1C=CC(O)=CC=1C1=NC2=CC=CC=C2N1C(CC(C)C)C(=O)NC1CCCCC1 ZTAROZANANJWTE-UHFFFAOYSA-N 0.000 description 1
• MZPSHOKGTZWKFE-UHFFFAOYSA-N n-cyclohexyl-2-[2-[4-(hydroxymethyl)phenyl]benzimidazol-1-yl]-4-methylpentanamide Chemical compound C=1C=C(CO)C=CC=1C1=NC2=CC=CC=C2N1C(CC(C)C)C(=O)NC1CCCCC1 MZPSHOKGTZWKFE-UHFFFAOYSA-N 0.000 description 1
• FUZZWVXGSFPDMH-UHFFFAOYSA-N n-hexanoic acid Natural products CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
• 230000007935 neutral effect Effects 0.000 description 1
• 231100000252 nontoxic Toxicity 0.000 description 1
• 230000003000 nontoxic effect Effects 0.000 description 1
• 150000007523 nucleic acids Chemical group 0.000 description 1
• 210000004940 nucleus Anatomy 0.000 description 1
• 239000003921 oil Substances 0.000 description 1
• 235000019198 oils Nutrition 0.000 description 1
• 150000007524 organic acids Chemical class 0.000 description 1
• 235000005985 organic acids Nutrition 0.000 description 1
• 150000007530 organic bases Chemical class 0.000 description 1
• 235000006408 oxalic acid Nutrition 0.000 description 1
• 230000037361 pathway Effects 0.000 description 1
• 239000000312 peanut oil Substances 0.000 description 1
• 230000002688 persistence Effects 0.000 description 1
• 229940124531 pharmaceutical excipient Drugs 0.000 description 1
• 229960003742 phenol Drugs 0.000 description 1
• 230000035479 physiological effects, processes and functions Effects 0.000 description 1
• 239000013612 plasmid Substances 0.000 description 1
• 229920005862 polyol Polymers 0.000 description 1
• 150000003077 polyols Chemical class 0.000 description 1
• 230000023603 positive regulation of transcription initiation, DNA-dependent Effects 0.000 description 1
• 239000011591 potassium Substances 0.000 description 1
• 229910052700 potassium Inorganic materials 0.000 description 1
• 239000001103 potassium chloride Substances 0.000 description 1
• WCUXLLCKKVVCTQ-UHFFFAOYSA-M potassium chloride Inorganic materials [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 1
• 235000011118 potassium hydroxide Nutrition 0.000 description 1
• 239000003755 preservative agent Substances 0.000 description 1
• MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
• 229960004919 procaine Drugs 0.000 description 1
• 230000008569 process Effects 0.000 description 1
• 238000012545 processing Methods 0.000 description 1
• 239000000047 product Substances 0.000 description 1
• 230000000750 progressive effect Effects 0.000 description 1
• NVRCQYNUBJFHBD-UHFFFAOYSA-N propan-2-yl 3-(3,4-difluorobenzoyl)-1-methyl-2,6-dihydro-1h-azepino[4,5-b]indole-5-carboxylate Chemical compound C1C(C)C(C2=CC=CC=C2N2)=C2C(C(=O)OC(C)C)=CN1C(=O)C1=CC=C(F)C(F)=C1 NVRCQYNUBJFHBD-UHFFFAOYSA-N 0.000 description 1
• CKTZVOQAMGTAQR-UHFFFAOYSA-N propan-2-yl 9-fluoro-3-(4-fluorobenzoyl)-1,1-dimethyl-2,6-dihydroazepino[4,5-b]indole-5-carboxylate Chemical compound C1C(C)(C)C(C2=CC(F)=CC=C2N2)=C2C(C(=O)OC(C)C)=CN1C(=O)C1=CC=C(F)C=C1 CKTZVOQAMGTAQR-UHFFFAOYSA-N 0.000 description 1
• XUWVIABDWDTJRZ-UHFFFAOYSA-N propan-2-ylazanide Chemical compound CC(C)[NH-] XUWVIABDWDTJRZ-UHFFFAOYSA-N 0.000 description 1
• 230000000069 prophylactic effect Effects 0.000 description 1
• VOGVOPWFCMDKIZ-UHFFFAOYSA-N propyl 3-(4-fluorobenzoyl)-2-methyl-2,6-dihydro-1h-azepino[4,5-b]indole-5-carboxylate Chemical compound CC1CC(C2=CC=CC=C2N2)=C2C(C(=O)OCCC)=CN1C(=O)C1=CC=C(F)C=C1 VOGVOPWFCMDKIZ-UHFFFAOYSA-N 0.000 description 1
• GXTAHEZYWBWLDM-UHFFFAOYSA-N propyl 8-fluoro-3-(4-fluorobenzoyl)-2-methyl-2,6-dihydro-1h-azepino[4,5-b]indole-5-carboxylate Chemical compound CC1CC(C2=CC=C(F)C=C2N2)=C2C(C(=O)OCCC)=CN1C(=O)C1=CC=C(F)C=C1 GXTAHEZYWBWLDM-UHFFFAOYSA-N 0.000 description 1
• 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
• 230000008439 repair process Effects 0.000 description 1
• 230000002441 reversible effect Effects 0.000 description 1
• 238000012552 review Methods 0.000 description 1
• 239000000523 sample Substances 0.000 description 1
• DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical compound CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 description 1
• 239000008159 sesame oil Substances 0.000 description 1
• 235000011803 sesame oil Nutrition 0.000 description 1
• 239000011734 sodium Substances 0.000 description 1
• 229910052708 sodium Inorganic materials 0.000 description 1
• 235000011121 sodium hydroxide Nutrition 0.000 description 1
• 239000004334 sorbic acid Substances 0.000 description 1
• 235000010199 sorbic acid Nutrition 0.000 description 1
• 229940075582 sorbic acid Drugs 0.000 description 1
• 238000010561 standard procedure Methods 0.000 description 1
• 230000001954 sterilising effect Effects 0.000 description 1
• 238000004659 sterilization and disinfection Methods 0.000 description 1
• 150000003431 steroids Chemical class 0.000 description 1
• 239000007929 subcutaneous injection Substances 0.000 description 1
• 238000010254 subcutaneous injection Methods 0.000 description 1
• 239000000126 substance Substances 0.000 description 1
• 235000000346 sugar Nutrition 0.000 description 1
• 150000008163 sugars Chemical class 0.000 description 1
• 239000000725 suspension Substances 0.000 description 1
• 238000013268 sustained release Methods 0.000 description 1
• 239000012730 sustained-release form Substances 0.000 description 1
• 208000024891 symptom Diseases 0.000 description 1
• 230000009897 systematic effect Effects 0.000 description 1
• WBWWGRHZICKQGZ-HZAMXZRMSA-N taurocholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCS(O)(=O)=O)C)[C@@]2(C)[C@@H](O)C1 WBWWGRHZICKQGZ-HZAMXZRMSA-N 0.000 description 1
• AWDRATDZQPNJFN-VAYUFCLWSA-N taurodeoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCS(O)(=O)=O)C)[C@@]2(C)[C@@H](O)C1 AWDRATDZQPNJFN-VAYUFCLWSA-N 0.000 description 1
• 229960004556 tenofovir Drugs 0.000 description 1
• VCMJCVGFSROFHV-WZGZYPNHSA-N tenofovir disoproxil fumarate Chemical compound OC(=O)\C=C\C(O)=O.N1=CN=C2N(C[C@@H](C)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C)C=NC2=C1N VCMJCVGFSROFHV-WZGZYPNHSA-N 0.000 description 1
• UGJBHBXXMCVEIH-UHFFFAOYSA-N tert-butyl 4-(2-ethoxycarbonyl-1-benzofuran-5-yl)piperazine-1-carboxylate Chemical compound C=1C=C2OC(C(=O)OCC)=CC2=CC=1N1CCN(C(=O)OC(C)(C)C)CC1 UGJBHBXXMCVEIH-UHFFFAOYSA-N 0.000 description 1
• PYSZFNGPNDZESE-UHFFFAOYSA-N tert-butyl 4-[2-(2H-tetrazol-5-yl)-1-benzofuran-5-yl]piperazine-1-carboxylate Chemical compound C(C)(C)(C)OC(=O)N1CCN(CC1)C=1C=CC2=C(C=C(O2)C2=NN=NN2)C=1 PYSZFNGPNDZESE-UHFFFAOYSA-N 0.000 description 1
• 230000004797 therapeutic response Effects 0.000 description 1
• RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 1
• 229940033663 thimerosal Drugs 0.000 description 1
• 230000000699 topical effect Effects 0.000 description 1
• CRDAMVZIKSXKFV-UHFFFAOYSA-N trans-Farnesol Natural products CC(C)=CCCC(C)=CCCC(C)=CCO CRDAMVZIKSXKFV-UHFFFAOYSA-N 0.000 description 1
• 238000001890 transfection Methods 0.000 description 1
• 238000012546 transfer Methods 0.000 description 1
• 230000005945 translocation Effects 0.000 description 1
• UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
• INASOKQDNHHMRE-UHFFFAOYSA-N turofexorate isopropyl Chemical compound C1C(C)(C)C(C2=CC=CC=C2N2)=C2C(C(=O)OC(C)C)=CN1C(=O)C1=CC=C(F)C(F)=C1 INASOKQDNHHMRE-UHFFFAOYSA-N 0.000 description 1
• 229940014499 ursodeoxycholate Drugs 0.000 description 1
• 229960001661 ursodiol Drugs 0.000 description 1
• 238000001291 vacuum drying Methods 0.000 description 1
• 238000009777 vacuum freeze-drying Methods 0.000 description 1
• 235000015112 vegetable and seed oil Nutrition 0.000 description 1
• 239000008158 vegetable oil Substances 0.000 description 1
• 239000003981 vehicle Substances 0.000 description 1
• 230000006656 viral protein synthesis Effects 0.000 description 1
• 230000017613 viral reproduction Effects 0.000 description 1